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Abstract
Introduction: Brain-derived neurotrophic factor (BDNF) facilitates neuronal
differentiation by activation of the TrkB receptor-tyrosine-kinase. BDNF/TrkB also
modulates the activity of the excitatory N-methyl-D-aspartate neurotransmitter receptor
(NMDAR), thereby also regulating neural plasticity and LTP/LTD, two forms of synaptic
plasticity that contribute to the storage of information inside the brain. How TrkB crosstalks to modulate NMDAR function is not known, although our working model involves
the RasGrf1 signaling molecule, a nucleotide exchange factor for Ras/Rac-GTPases,
which interacts with both receptors. In response to TrkB activation, Ras-Grf1 is tyrosine
phosphorylated and mediates neurite outgrowth in PC12 cells. RasGrf1 also binds
constitutively to the NMDAR to stimulate long-term-depression (LTD) in primary
neurons. We hypothesize that TrkB activation of Ras-Grf1 will increase neuronal
outgrowth in TrkB expressing PC12 derived cells (TrkB-B5) and BDNF will uncouple
RasGrf1 from the NMDAR thereby facilitating a decrease in LTD and an increase in
long-term-potentiation (LTP) in primary neurons.
Method: PC12 (TrkB-B5) cells were transfected with appropriate plasmids,
treated with BDNF (1ng/ml) and the percentage of neurite outgrowth was determined.
Brain tissue slices from P30 mice were stimulated with either BDNF (100 ng/ml),
NMDA (100 µM) or co-stimulated with both. Slices were then lysed and the protein
interactions were assayed by immunoprecipitation and western blotting.
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Results: We found that RasGrf1 expression significantly (P-value <0.05)
increases neurite outgrowth in cell culture, in response to BDNF, which was dependent
on the activation of both Ras and Rac. Although Tyr1048 and Tyr1062 appeared to be
crucial sites of tyrosine phosphorylation on RasGrf1 for neurotrophin mediated neurite
outgrowth in cell culture, tyrosine phosphorylation of RasGrf1 could not be detected in
neural tissue slices in response to BDNF. Furthermore, we found a direct interaction
between RasGrf1 and TrkB receptor in response to BDNF treatment in slice cultures. In
addition, BDNF stimulated the tyrosine phosphorylation of the NR2B subunit of the
NMDA receptor at residue Tyr1472, which facilitates receptor retention at the cell surface,
and also stimulated a dissociation of RasGrf1 from the NMDA receptor.
Conclusion: My results strongly suggest that BDNF stimulation changes
NMDAR signaling via TrkB activation and that this is mediated by RasGrf1. Future
studies using RasGrf1 knockout mice will further address BDNF dependent changes in
the activation of individual signalling molecules, and hippocampal culture studies from
wild-type/RasGrf1 knock-out mice will address whether changes in BDNF-induced
neuronal dendritic growth and spine formation are dependent on RasGrf1.

Keywords: RasGrf1, NMDA receptor, TrkB, NR2B subunit, neurotrophins, neurite
outgrowth, BDNF, NMDA, Ras, Rac, LTP, LTD, synaptic plasticity.
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Chapter 1
Cross-talk between Trk and NMDA receptors
1.1 Neurotrophins and the receptors termed tropomyosin-related kinase (Trk)
Neurotrophins, including nerve growth factor (NGF), brain-derived neurotrophic
factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4/5 (NT 4/5), belong to a family
of closely related growth factors (Meakin, 2000; Reichardt, 2006). Structurally, these
proteins are homodimers with molecular weights of ~26 kDa and consist of 118-129
amino acid subunits (McDonald et al., 1991; Robinson et al., 1995; Butte et al., 1998).
They are derived from a precursor protein so called pre-proneurotrophin, which consists
of about 250 residues with a signal sequence and a prodomain followed by the mature
neurotrophin sequence (Lessmann and Brigadski, 2009).
NGF was discovered in the 1950s as an essential growth factor in the developing
nervous system (Levi-Montalcini, 1987; Shooter, 2001) while BDNF, as the second
neurotrophin to be identified, was originally purified from brain lysates and was found to
have high amino acid sequence homology to NGF (Barde et al., 1982). Subsequently,
other members of the neurotrophin family were isolated using RT-PCR techniques and
primer sequences conserved between NGF and BDNF (Barde et al., 1982; Berkemeier et
al., 1991). The neurotrophins exert their biological activity by binding to and activating a
low affinity receptor termed, p75, and one or more members of the high affinity
tropomyosin-related kinase (Trk) family of receptors. trkA was originally identified as a
transforming oncogene from a human colon tumor as a rearrangement between a gene
encoding an intracellular tyrosine kinase domain with an extracellular sequence from a
non-muscle tropomyosin gene and was so called the tropomyosin-related kinase (trk).
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Subsequently, trkB and trkC were discovered based on high sequence homology to trkA
(Martin-Zanca et al., 1986; Klein et al., 1989).
Structurally, Trk receptors contain two cysteine clusters, with three leucine-rich
motifs in between, followed by two immunoglobulin-like domains in the extracellular
region (Figure 1.1), a transmembrane region and an intracellular tyrosine kinase domain
with 5 effective tyrosine residues. All reigons in the extracellular domains are contributed
directly or indirectly in ligand-Trk binding although the immunoglobulin-like domains
are the major interfaces in this precess. Besides, from an evolutionary perspective, Trk
receptors (A, B and C) are highly conserved in both intracellular and extracellular
domains among vertebrates (Benito-Gutierrez et al., 2006). In comparison, the p75
receptor contains four cysteine-rich domains on the extracellular side as well as an
intracellular death domain similar to that first described in tumor necrosis factor receptor
(NTR) family members (Liepinsh et al., 1997; Chao and Hempstead, 1995; Huang and
Reichardt., 2003; He and Garcia, 2004). Although p75 shares no sequence homology to
Trk, the three-dimensional structure of its extracellular domain has been shown to form a
binding site for the NGF dimer involving all four cysteine-rich repeats (He and Garcia,
2004).
The two different receptor classes of p75 and Trk have distinct preferences for the
two forms of ligands; namely, pro-neurotrophins for p75NTR and mature neurotrophins for
Trk receptors. In this respect, NGF binds TrkA, BDNF binds TrkB, NT-3 binds TrkC,
and NT-4/5 binds both TrkB and TrkC. In addition to binding Trk receptors with high
affinity (nM), all mature neurotrophins can bind with low affinity to p75 (µM). In
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contrast, all pro-neurotrophins bind with high affinity to p75 (Figure 1.1) (Meakin, 2000;
Reichardt, 2006; Frade and Barde, 1998).
A general consequence of Trk receptor tyrosine kinase activation includes cell
survival, neuronal growth and differentiation, as well as a specific role of TrkB in
modulating synaptic plasticity in the central nervous system (Meakin, 2000; Reichardt,
2006). In contrast, neurotrophin-mediated activation of p75NTR initiates signaling
pathways leading to apoptosis (Lee et al., 2001; Song et al., 2002). However, recent
studies have also shown some roles for Trk receptor signaling outside the nervous system
including cardiac development, neovascularization and in the immune system (Donovan
et al., 2000; Lin et al., 2000; Coppola et al., 2004; Kermani et al., 2005).

4
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Figure 1.1. A schematic diagram of the neurotrophin receptor subtypes p75NTR and
the receptor tyrosine kinase family of Trk receptors. Tropomyosin related kinases
(Trk), including TrkA, B and C, are receptors for a family of growth factors including
NGF which binds TrkA, BDNF and NT 4/5 which bind TrkB and NT3 which binds
TrkC. Moreover, all neurotrophins bind p75 receptor with low affinity while all proneurotrophins bind p75 with high affinity. Structurally, Trks have an extracellular region
containing 2 cysteine-rich clusters (CC), leucine rich motifs (LRM) and immunoglobinlike domains (Ig-D), and also an intracellular tyrosine kinase domain (KD) with 5
tyrosine residues which can be auto-phosphorylated upon binding to the ligand and
dimerization. These phosphorylation sites on TrkB include Tyr516 Tyr702, Tyr706, Tyr707
and Tyr817 which are equivalent to Tyr499, Tyr679, Tyr683, Tyr684, and Tyr794 on TrkA. In
addition, the p75NTR consists of four cysteine rich motifs (CRM) as wells as an
intracellular death domain (DD).
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1.2 Neurotrophins and Trk expression
The expression pattern and localization of neurotrophins and their receptors varies
depending on regions within the peripheral and central nervous systems. Table 1
summarizes the pattern of neurotrophins and their receptor expression in different tissues
of the nervous system (Korsching and Thoenen, 1983; Heumann et al., 1984; Davies et
al., 1987; Heumann et al., 1987; Korsching, 1993; Eide et al., 1993; Avila et al., 1993;
Ernfors et al., 1992; Knusel et al., 1991; Hyman et al., 1991; Ernfors et al., 1990). Note
that generally in the hippocampus, TrkB receptors are localized in the axons, nerve
terminals and dendritic spines of glutamatergic neurons (Drake et al., 1999). In particular,
although TrkA is not expressed inside the hippocampus, NGF is expressed and secreted
in the hippocampus to activate TrkA receptors in the termini of cholinergic neurons
projecting from the basal forebrain (Meakin, 2000). Once action potentials are
propagated at the nerve terminal, which results in the opening of voltage-gated channels
on the presynaptic membrane and fusion machinery are activated , secretory vesicles of
neurotrasmitter are released in either regulative or constitutive pathways. NGF is secreted
predominately in a constitutive way specifically in hippocampal neurons while BDNF
transcription and secretion are regulated in an activity-dependent manner (Mowla et al.,
1999; Farhadi et al., 2000; Lessmann et al., 2003; Lu, 2003). Neuronal activity
remarkably increases BDNF expression in hippocampal neurons, and its release in the
presynaptic membrane in response to an increase in calcium concentration (Patterson et
al., 1992; Dragunow et al., 1993; Kuczewski et al., 2009). Activity-dependent secretion
of BDNF appears to be important for normal hippocampal function as a mutation in
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BDNF prodomain (Val

66

to Met) impairs BDNF trafficking and increases the

susceptibility to neuropsychiatric disorders (Egan et al., 2003; Hariri et al., 2003).

Table 1.1. Neurotrophin and Trk expression pattern in various areas of the nervous
system.
Tissues

NGF

TrkA

BDNF

TrkB

+

+

+

+

Motor Neurons

++

+

Cerebral Cortex

+

+

+

+

+

+

+

+

+

+

Dorsal Root Ganglia
(DRG)
Sympathetic Ganglia

Cholinergic Neurons

TrkC
+

+

Striatum
Hippocampus

NT3

+
+
+

GABAergic Neurons

+

Dopaminergic Neurons

+

Cerebellum

+

Hypothalamus

+

+
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1.3 Neurotrophin-mediated Trk activation
Neurotrophins initiate their signal transduction through activation of their
receptors, Trk or p75NTR. In case for Trk, once neurotrophins bind, the receptor tyrosine
kinase is dimerized, which results in tyrosine-autophosphorylation in the intracellular
kinase domain. The major sites of phosphorylation on rat TrkA include tyrosine residues
499, 679, 683, 684, and 794. While tyrosine residues 679, 683 and 684 in the kinase
domain remain in an open conformation in the inactive receptor, these phosphorylation
sites form a stable activation loop by conformational change upon phosphorylation which
subsequently, with further phosphorylation of tyrosine 499 and 794, serve as docking
sites for intermediate signaling (adaptor) molecules leading to activation of distinct
pathways and diverse physiological responses (Hanks et al., 1988; Ibanez et al., 1993;
Heldin, 1995; Hubbard, 1997).
One such adaptor molecule is the Src homology 2 (SH2)-domain containing
protein Shc (ShcA, B and C) which binds to phosphorylated tyrosine at position Y499 by
its phosphotyrosine binding (PTB) domain, and another adaptor molecule is Fibroblast
growth factor Receptor Substrate 2 (FRS2) which competes with Shc to bind at this site
(Liu and Meakin, 2002; Stephens et al., 1994; Meakin et al., 1999). Adaptor proteins are
intermediate signaling molecules that mediate specific protein-protein interactions
without intrinsic enzymatic activity. In addition, Pleckstrin homology (PH) or Src
homology 2 (SH2) domain containing proteins also bind to other tyrosine sites on Trk
and activate Trk-mediated signaling pathways. Another major signaling protein is
phospholipase Cγ-1 (PLCγ-1) which binds to phosphorylated tyrosine at position Y794,
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activation of which results in an increase in intracellular Ca2+ concentration (Minichiello,
2009).
Through these adaptor molecules, Trk receptors are able to activate three major
signaling pathways (Figure 1.2) including the Ras-mitogen activated protein kinase (RasMAPK) pathway, the phosphotidylinositol-3 kinase (PI3K)-Akt pathway, and the PLCγ-1
pathway (Barbacid, 1994; Huang and Reichardt, 2003; Reichardt, 2006; Minichiello,
2009).
In the Ras-MAPK pathway, phosphorylated Trk at position 516 of TrkB
(Kavanaugh and Williams, 1994), or analogous sites on TrkA and TrkC, mediate Shc
activation and recruitment of the adaptor protein Grb2 (growth factor receptor-bound
protein 2) and the SOS (son of sevenless) guanine nucleotide exchange factor, leading to
activation of Ras-GTPase and the kinase c-Raf-1 (English and Sweatt, 1997; Reichardt,
2006; Minichiello, 2009). Subsequently, associated Mek1/2 kinases are activated
resulting in a transient activation of Erk1/2 MAP kinases which underlie proliferation and
cell cycle progression (English and Sweatt, 1997; Reichardt, 2006; Minichiello, 2009). In
contrast, Trk-mediated FRS2 activation recruits the adaptor protein Crk, the C3G
nucleotide exchange factor leading to activation of Rap-1 GTPase, and the kinase b-Raf
which subsequently results in prolonged activation of Erk1/2 MAP kinase underling cell
cycle arrest and differentiation (Kao et al., 2001; Wu et al., 2001; Egan et al., 1993).
Through the PI3K-Akt pathway, phosphotidylinositol-3 kinase is activated in
either Ras-independent or Ras-dependent pathways. In the Ras-independent pathway, the
Gab1 (GRB-associated binder-1 adapter) is recruited to TrkB indirectly through Grb2,
and in turn binds to PI3K. Upon this association, PI3K is able to convert
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phosphatidylinositol (PtdIns) into phosphatidylinositol 3-phosphate (PI3P), and in the
presence of PI3P, the 3-phosphatidylinositide-dependent protein kinases (PDPK-1&2) are
able to activate the Akt protein kinase (or protein kinase B). Akt can prevent cell death or
apoptosis by phosphorylation (inactivation) of pro-apoptotic proteins and activating
growth promoting substrates that underlie cell survival (Yuan and Yankner, 2000; Brunet
et al., 1999; Yuan et al., 2003; Sini et al., 2004; Huang and Reichardt., 2003; Minichiello,
2009).
In contrast, in the phospholipase Cγ-1 pathway, Trk-mediated activation of PLCγ1 hydrolyses phosphotidylinositol 4,5-biphosphate (PtdIns 4,5-P2 ) to generate inositol
1,4,5-triphosphate (Ins 1,4,5-P3) and diacylglycerol (DAG). InsP3 promotes the release of
Ca2+ from the endoplasmic reticulum, while DAG stimulates protein kinase C (PKC)
activation at the cell surface (Zirrgiebel et al., 1995; Roback et al., 1995; Patapoutian and
Reichardt., 2001; Huang and Reichardt., 2003; Minichiello, 2009). Increases in Ca2+
levels result in the activation of a wide variety of signaling proteins underling synaptic
plasticity including protein kinase A (PKA) and calcium/calmodulin-dependent kinases
(CaMKII, CaMKK and CaMKIV) (Huang and Reichardt., 2003; Minichiello, 2009).
Collectively, it appears that by three different major pathways mentioned above, Trk
receptors are able to finally activate four different protein kinases upstream of MAPkinases, including PKA (cAMP-dependent protein kinases), PKB (PI3K-dependent
protein kinases), PKC (DAG-dependent protein kinases), and Ca2+-dependent protein
kinases.
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Figure 1.2. A schematic diagram of three major Trk-mediated signaling pathways.
1) In Ras-Erk pathway (white color), tyrosine phosphorylation of Trk at position 516
(Y499 on TrkA) activates the Shc adaptor protein which in turn recruit Sos and Grb2,
leading to activation of Ras and transient activation of Erk1/2 underlying cell
proliferation. Moreover, FRS2 (blue color) competes with Shc to couple Trk to Rap-1
which leads to sustained activation of Erk1/2 underlying neural differentiation. 2). PI3K
pathway (grey color) acts indirectly through Grb2 downstream of TrkB to recruit Gab1 or
directly through Ras. In response to this association, PI3K activates Akt leading to cell
survival. 3) In the PLCγ-1 pathway (yellow color), phospholipase Cγ-1 binds to
phosphorylated tyrosine at position 817 (Y794 on TrkA) resulting in an increase in
intracellular Ca2+ concentration, which in turn results in the activation of a wide variety of
signaling proteins underling synaptic plasticity. RasGrf1
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1.4 Trk and clinical disorders
Several isoforms of TrkA, B and C have been reported in different studies, some
of which are associated with clinical disorders either due to changes in the expression
level or a mutation in both receptors and neurotrophins. For instance, a decrease in BDNF
levels were reported in the postmortem brain of Parkinson’s patients (Nagatsu and
Sawada, 2007), and in the limbic structure of patients with depression, epilepsy and
bipolar disorder (Kozisek et al., 2008; Ren and Dubner, 2007). These group of patients
exhibit atrophy in the hippocampus and prefrontal cortex in which treatment with antidepressants increases BDNF expression and its function, resulting in limitation of the
side effects and atrophy (Monteggia et al., 2007). A mutation in BDNF (V66M) increases
the susceptibility of patients to neuropsychiatric disorders with memory impairment due
to deficits in BDNF transport and decreases in BDNF secretion levels (Chen et al., 2006;
Bath and Lee, 2006; Egan et al., 2003). As such, BDNF has been suggested as a potential
therapeutic agent for neurogolical and psychiatric disorders such as Alzheimer’s,
Parkinson’s, Huntington’s, Stroke, Spinal cord injury, and also to regulate metabolic
disorders such as Obesity and Diabetes due to a high expression of BDNF in the
ventromedial hypothalamus which regulates appetite and food intake (Nagahara and
Tuszynski, 2011). In addition, TrkB has been suggested as a therapeutic target for several
types of human cancers such as neuroblastoma, prostate and pancreatic adenocarcinomas,
and liver metastases (Desmet and Peeper, 2006). Recent studies have also reported a
correlation between Alzheimer’s disease and impairment in NGF transport from the
hippocampus and neocortex to cholinergic neurons of the basal forebrain (Schindowski et
al., 2008) as well as mutations in the trkB gene (Vepsalainen et al., 2005).
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Moreover, alternative splicing of TrkA generates an isoform with an additional 6
amino acid residues in the proximal region of the extracellular domain. This isoform
gains the additional ability to bind NT3 and being predominantly expressed in neuronal
cells while TrkA lacking this additional amino acid fragment binds specifically to NGF
(Barker et al., 1993). Truncated TrkB and TrkC isoforms, lacking a functional motif in
the intracellular domain, have been also described as being able to inhibit full length Trk
perhaps by forming non-functional heterodimers with full length subunits (Middlemas et
al., 1991; Tsoulfas et al., 1993; Eide et al., 1996; Palko et al., 1999; Rose et al., 2003). A
dominant mutation on TrkB in an activation loop tyrosine (Y722C) has also been observed
in patients with severe early onset hyperphagia (excessive appetite) as well as being
associated with a severe impairment in learning and memory (Yeo et al., 2004).
Moreover, an alternative splicing isoform of TrkC containing additional 14-39 amino
acids residues in the intracellular kinase domain has also been reported to reduce the
ability of the receptor to activate downstream signaling adaptors such as Shc and PLCγ
(Reichardt, 2006; Barbacid, 1994). Trk receptors have also been shown to co-ordinate
and co-operate with other receptors including G protein-coupled receptors (GPCR)
(Weise et al., 2007; Lee and Chao, 2001; Lee et al., 2002a&b; Rajagopal et al., 2004),
AMPA receptors (Wu et al., 2004; Caldeira et al., 2007) as well as NMDA receptors
(Kang and Schuman, 2000; Amaral and Pozzo-Miller, 2007; Wu et al., 2004; Xu et al.,
2006).
1.5 Neurotrophins and Trk regulation
Several mechanisms regulate neurotrophins and Trk expression, secretion and
their function. Neurotrophins are regulated by membrane insertion, through intra and
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extracellular trafficking, and by changes in protease activity (Thoenen and Barde, 1980).
Since some proteases convert pro-neurotrophins to mature neurotrophins, and proneurotrophins have high affinity binding to p75NTR to activate signaling pathways leading
to apoptosis (Lee et al., 2001), low protease activity can regulate mature neurotrophin
levels. In fact, it has been shown that mature BDNF facilitates hippocampal long term
potentiation (LTP) through TrkB while pro-BDNF promotes long term depression (LTD)
through p75NTR (Patterson et al., 1996; Minichiello et al., 2002), and several studies
suggest that enhanced pro-neurotrophin levels following brain injury may increase
neuronal loss due to binding and activation of p75NTR (Fahnestock et al., 2001;
Harrington et al., 2004; Pedraza et al., 2005).
Trk is localized intracellularly inside membranous vesicles in the absence of
signals. However, signals such as cAMP, electrical activity or calcium increase the
insertion of Trk into the plasma membrane (Barker et al., 2002; Heerssen and Segal,
2002). The ligand-activated Trk complex is internalized through clathrin coated pits
(Valdez et al., 2005) while its extracellular part is bound to ligand and intracellular side
associated with a number of signaling molecules such as PLCγ, PI3K or Ras-MAP kinase
(Grimes et al., 1996; Howe et al., 2001). These endosomal vesicles are then transported retrogradely

to the cell soma where they activate other Trk-dependent substrates (Wu et al., 2001;
York et al., 2000; Delcroix et al., 2003; Huang et al., 1999; Huang and Reichardt, 2003).

1.6 NMDA receptor
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The N-methyl-D-aspartate (NMDA) receptor is an ionotropic channel (Figure
1.3A) that upon activation by glutamate in vivo or NMDA stimulation in vitro, allows the
flow of Na+, and to a lesser extent Ca2+, into the cell as well as K+ out of the cell.
It is a heterotetrameric complex predominately made up of two obligatory NR1
subunits which bind to glycine and two modulatory NR2 subunits which bind to
glutamate and control the electrophysiological properties of the NMDA receptor.
Recently, growing evidence suggests that there are also glycine-binding NR3 subunits in
the structure of NMDA receptors. NR1 subunits consist of eight different subtypes
alternatively spliced from a single gene. NR2 subunits consist of four different A-D
subtypes while NR3 subunits consist of two different A and B subtypes and together with
NR2, they are encoded by six separate genes (Kutsuwada et al., 1992; Monyer et al.,
1992; Paoletti, and Neyton, 2007).
While NMDA receptors contribute to both LTP and LTD, several studies suggest
that NR2A subunits of the NMDA receptor promote LTP whereas NR2B subunits
contribute to LTD (Li et al, 2006; Kollen et al., 2008; Liu et al., 2004; Massey et al.,
2004).
The cell surface localization of the NMDA receptor is regulated through clathrinmediated endocytosis in which the

1472

YEKL internalization motif on the NR2B subunit

serves a pivotal role in this process. Phosphorylation of tyrosine 1472 (Tyr1472) of the
YEKL motif by Src family kinases uncouples the NMDA receptor from clathrinmediated internalization and increases the retention and activity of the receptor at the cell
surface (Nakazawa et al., 2001; Prybylowski et al., 2005).
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Figure 1.3. A schematic diagram of the NMDA receptor and physiological events
during neurite outgrowth, Long Term Potentiation and Long Term Depression. A)
The NMDA receptor is an ionotropic channel that upon activation allows the flow of Na+
and small amounts of Ca2+ ions into the cell and K+ out of the cell. It is a heterotetrameric
complex made up of two obligatory NR1 and two modulatory NR2 subunits. It has been
shown that RasGrf1 binds to the NR2B subunit of NMDA receptor (Krapivinsky et al.,
2003). B) The major physiological events that occur during LTP and LTD. In LTP, there
is an increase in the postsynaptic transmission of ions such as Na+, K+ and Ca2+ rather
than weakening of postsynaptic transmission during LTD. LTP can be induced with a
high-frequency stimulation through receptors present on the surface of the postsynaptic
membrane, rather than a low frequency stimulation that stimulates LTD. LTP is an
outcome of an increase in the activity of the receptors either by increasing the number of
receptors on the postsynaptic cell surface or by increasing presynaptic factors, whereas
LTD is an outcome of a decrease in the activity of these same receptors. Ca2+ entry above
threshold is associated with LTP and low Ca2+influx leads to LTD.
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1.7 Long Term Potentiation (LTP) and long Term Depression (LTD)
LTP and LTD are two forms of synaptic plasticity that contribute to the storage of
information during different types of learning and memory inside the brain, particularly
in the hippocampus area of the brain (Table 2) (Lau and Zukin, 2007; Lu et al., 2008;
Lynch, 2004). LTP lasts for hours up until days and involves gene expression and new
protein synthesis, and it is in contrast to Short Term Potentiation (STP) which lasts
seconds up until minutes involving the interaction between existing proteins and is
independent of gene expression and protein synthesis (Figure 1.3B) (Lynch, 2004; Lu et
al., 2008; Minichiello, 2009).
LTP can be induced with high-frequency stimulation of receptors present on the
surface of the postsynaptic membrane (Figure 1.3B), which results in an increase in the
postsynaptic transmission of ions such as Na+, K+ and Ca2+. In contrast, LTD is an
outcome of low frequency stimulation, a decrease in the activity of the NMDA receptor,
and weakening of postsynaptic transmission. The outcome of both LTP and LTD are
changes in intracellular Ca2+ concentrations, as Ca2+ entry above a threshold is associated
with LTP and a modest increase in Ca2+ level leads to LTD (Lu et al., 2008; Minichiello,
2009). LTP represents improved communication between two neurons and is mediated by
the excitatory neurotransmitter glutamate in vivo or NMDA in in vitro studies.
LTP is observed not only in the hippocampus, but also in other neural structures
including the cerebral cortex, cerebellum or amygdala (Bauer et al., 2002; Nakazawa et
al., 2006; Minichiello, 2009). In general, LTP can be dependent or independent on
NMDA receptors. However, the NMDA receptor-dependent is the most widely studied
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model of LTP in the CA3-CA1 (Cornu Ammonis) area of the hippocampus (Lisman,
2003).
Table 1.2. Different types of learning and memory in various areas of the brain.
Types of learning/memory

Brain area involved

Spatial memory

Hippocampus, Parahippocampus, Subiculum, Cortex,
Temporal cortex, Area 47, Posterior parietal cortex

Emotional memory

Amygdala

Recognition memory

Hippocampus, Temporal lobe

Working memory

Hippocampus, Prefrontal cortex

Motor skills

Striatum, Cerebellum

Sensory (visual, auditory,

Various cortical area

tactile)
Classical conditioning

Cerebellum

Habituation

Basal ganglia

1.8 BDNF-mediated TrkB activation and neural plasticity
The TrkB receptor is expressed widely inside the brain including the cortex and
hippocampus and in addition to its well known effects on neuronal outgrowth and
differentiation, TrkB activation is crucial in various aspect of synaptic plasticity in the
entire brain including the cortex, hippocampus, cerebellum and amygdala (Carvalho et
al., 2008; Lu et al., 2008). TrkB receptors have been found on both presynaptic and
postsynaptic membranes of the nerve terminal and dendritic spines, and BDNF-mediated
TrkB receptors have been suggested to modulate dendritic branches and spine formation
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during neural plasticity within cortical, cerebellar and hippocampal synapses (Amaral et
al., 2007; Minichiello, 2009).
BDNF plays a role in synaptic transmission on the postsynaptic membrane in
addition to its well known effects on neuronal outgrowth and differentiation (Tyler et al.,
2002). Although the mechanism by which BDNF regulates NMDA receptor-mediated
neural plasticity is poorly understood, it appears that by indirectly modulating NMDA
receptor activity, BDNF helps to regulate two important processes of learning and
memory, namely LTP and LTD (Xu et al., 2006; Kang et al., 1997; Akaneya et al., 1997;
Lessmann and Heumann, 1998; Levine et al., 1998; Levine and Kolb, 2000; Li et al.,
1998). The evidence for a role of BDNF-mediated TrkB activation in LTP comes from
the fact that any deletion in the bdnf or trkB genes, or in vivo blocking of BDNF binding
to TrkB and pre-treating hippocampal slices with anti-TrkB antiserum, can either impair
or significantly reduce the induction of LTP (Minichiello, 2009). Further studies have
also suggested that NMDA receptor activity can increase BDNF expression leading to
further TrkB-mediated regulation of NMDA receptors during synaptic plasticity
(Caldeira et al., 2007).
BDNF activates TrkB receptors, which upon activation in turn modulates the
tyrosine phosphorylation status of the NR2B subunits of NMDA receptors and increases
the retention of these receptors on the postsynaptic cell surface (Nakazawa et al., 2001;
Prybylowski et al., 2005). As a result of prolonged surface retention of the NMDA
receptor, and the ability to respond to L-glutamate, the intracellular calcium levels
increase in the postsynaptic neuron (Minichiello, 2009; Lin et al., 1998; Levine et al.,
1998; Levine and Kolb, 2000). Increases in Ca2+ influx in postsynaptic neurons finally
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influences the physiological properties and trafficking of the postsynaptic glutamate
receptors such as the NMDA receptor through phosphorylation/ dephosphorylation, and
results in the activation of a number of signaling molecules including PKC, PKA and the
calcium-sensitive calmodulin-activated kinases (CaMKI, II and IV) (Ghosh and
Greenberg, 1995; West et al., 2001; Minichiello, 2009), leading to initiation of signaling
cascades that underlie neuronal growth, development and synaptic plasticity (Li et al.,
2006; Minichiello, 2009).
Among these kinases, PKA and CaMK have been suggested to phosphorylate the
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) type of glutamate
receptor that is involved primarily in the postsynaptic membrane depolarization and the
maintenance of LTP, and also the NMDA receptor which is implicated in the induction or
initiation of LTP (Lynch, 2004; Soderling and Derkach, 2000; Song and Huganir, 2002;
Malenka and Bear, 2004). Furthermore, they activate a Ras-guanine nucleotide releasing
factor termed RasGrf1 (Farnsworth et al., 1995) through either serine phosphorylation at
residue 916 (S916) on RasGrf1 (Schmitt et al., 2005) or unknown sites of tyrosinephosphorylation by the non-receptor tyrosine kinases Src (Kiyono et al., 2000a) and Ack1
(Kiyono et al., 2000b).
1.9 RasGrf1 is a common substrate of both TrkB and NMDA receptors
RasGrfs belong to a family of guanine nucleotide exchange factors (GEFs), other
members of which include Sos (Simon et al., 1991; Ferrari et al., 1994) and C3G
(Knudsen et al., 1994; Tanaka et al., 1994). RasGrf is present in two forms. One form is
RasGrf1 (140 kDa with 1262 amino acids) which is highly expressed in the nervous
system (Zippel et al., 1997). The other form is RasGrf2 (130 kDa with 1189 amino
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acids), which shows a high degree of sequence homology (80%) to RasGrf1, and is
expressed ubiquitously, but is also present within the mature brain (Fam et al., 1997;
Anborgh et al., 1999).
The expression pattern and localization of RasGrf1 has been extensively studied
in the rat brain. The full length RasGrf1 protein is expressed in mature neurons of the rat
brain and spinal cord, but not in glial cells. The hippocampus, amygdala, thalamus,
hypothalamus, cortex, striatum, cerebellum, and retina are the major sites of full length
RasGrf1 protein expression (Itier et al., 1998; Shou et al., 1992; Wei et al., 1993; Zippel
et al., 1997; Fernandez-Medarde et al., 2009), and later sub-cellular fractionation studies
have indicated the presence of RasGrf1 in post-synaptic densities and its localization in
the dendrites and soma of neuronal cells (Zippel et al., 1997; Sturani et al., 1997).
Outside the nervous system, RasGrf1 is also expressed in lower levels in pancreatic βcells suggesting that it might be involved in normal pancreas development, glucose
haemostasis and Diabetes (Itier et al., 1998; Font de Mora et al., 2003; Hoffmann and
Spengler, 2012).
Mouse RasGrf1 was originally identified (Shou et al., 1992) as a homologue to
CDC25 (cell division cycle 25), an activator of Ras-GTPase, in the yeast S. cerevisiae,
and was initially so called CDC25Mm (Martegani et al., 1992; Wei et al., 1992).
Subsequently, a 140 kDa RasGrf1 was isolated from Rat brain homologous to
CDC25Mm (Gariboldi et al., 1994), and further study in the mouse brain led to isolation
of other naturally occurring splice variants of RasGrf1 including a 58 kDa and 20 kDa
truncated products (Ferrari et al., 1994; Arava et al., 1999; Feig, 2011). The 58 kDa
isoform is expressed predominantely during embryogenesis while the full length 140kDa-
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RasGrf1 is expressed in the mature mouse brain (Ferrari et al., 1994). The small isoform
of 20kDa has been identified predominantely in the mouse pancreas (Arava et al., 1999).
Mouse RasGrf1 is located on chromosome 9 with 26 exons (de la Puente et al.,
2002) while RasGrf2 is located on the long arm of chromosome 13 with 24 exons.
Human RasGrf1 is largely similar to mouse RasGrf1 with 82.7% sequence homology. An
extra small fragment of full length hRasGrf1 with 1273 amino acids does not affect the
function of any conserved domains (Fernandez-Medarde and Santos, 2011). RasGrf1 is
an imprinted gene (preferentially from the paternal allele) which is expressed only after
birth in the mouse, rat and human, and its transcription is mostly regulated through
methylation and alternative splicing mechanisms (Plass et al., 1996; Kaneda et al., 2004;
Fernandez-Medarde and Santos, 2011).
Structurally, RasGrf1 is a large multi-domain protein that is recruited by a diverse
range of signaling molecules (Figure 1.4). These domains include a pleckstrin homology
(PH) domain in the amino-terminus, a coiled coil (CC) and ilimaquinone (IQ) motif, a
Db1 homology domain (DH), a Ras exchange motif (REM), a cyclin destruction box
(CDB) and a cell division cycle 25 (CDC25) domain in the C-terminus (FernandezMedarde and Santos, 2011).
Among these domains, the PH domain, which is necessary for RasGrf1
localization in the plasma membrane (Buchsbaum et al., 1996), has been suggested being
able to bind to phosphoinositides and other types of phospholipids in the membrane
(Harlan et al., 1994; Lemmon and Ferguson, 2000; Varnai et al., 2002), also acts as
putative phosphotyrosine binding (PTB) domain (Balla, 2005; Cowburn, 1997). RasGrf1
can also bind to βγ subunits of G protein-coupled receptors via the PH1 domain (Touhara
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et al., 1994; Shou et al., 1995; Mattingly and Macara, 1996; Zippel et al., 1996) and has
also been shown to interact with Trk family receptor tyrosine kinases via their HIKE
motifs (Robinson et al., 2005). Coiled coil domains play a role in protein-protein
interactions in cooperation with PH1 and IQ domains (Buchsbaum et al., 1996), but no
specific function has been reported for this domain.
The IQ domain is capable of interacting with the protein calmodulin in a Ca2+independent manner. In response to calcium elevation, RasGrf1 is activated by binding of
calcium/calmodulin to the IQ motif (Buchsbaum et al., 1996; Farnsworth et al., 1995).
Moreover, it has been revealed that a point mutation in the IQ domain, which blocks
calmodulin binding, can in fact prevent calcium-induced Ras activation (Buchsbaum et
al., 1996). The DH domain binds the Rho family of GTPases, in particular Rac1, and
promotes guanine nucleotide exchange activity toward Rac1 (Freshney et al., 1997;
Kiyono et al., 1999; Innocenti et al., 1999). It has been suggested that DH domain might
contribute to RasGrfs oligomerization (Anborgh et al., 1999), and in association with the
adjacent PH2 domain, they can mediate interaction with other intracellular compartments
such as microtubules, microtubule-binding proteins (Forlani et al., 2006; Baldassa et al.,
2007).
The REM motif plays a role in stabilization of the core CDC25 domain and the
CDB or PEST domain is a region between the REM and CDC25 domains which is rich in
proline, glutamic acid, serine and threonine amino acids and constitutes a hypothetical
target for proteolysis, an additional mechanism to regulate the cellular levels of RasGrf1
protein (Rogers et al., 1986; Baouz, et al., 1997;; Gnesutta et al., 2001). Lastly, the
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CDC25 domain facilitates the activation of the Ras-GTPase (Tian and Feig, 2001; Cen et
al., 1993; Wei et al., 1994).
A role for GEFs in general, and RasGrfs in particular, is to promote the exchange
of GDP for GTP on small GTPase proteins such as Ras and Rac which act as molecular
switches of active GTP-bound and inactive GDP-bound states (Tian et al., 2004; Katoh et
al., 2000). Initially, a transient GEF-GTPase-GDP complex is formed by binding of GEF
to GTPase-GDP which promotes a conformational change in the GTPase structure and
release of GDP. Subsequently release of GDP results in formation of a stable GEFGTPase-GTP complex. Finally, the GEF is released and the activated GTPase can in turn
activate various signaling cascades (Tian and Feig, 2001; Consonni et al., 2003). In
contrast to GEFs, GTPase Activating Proteins (GAPs) have been suggested to inactivate
Ras-GTPases by hydrolyzing GTP bound to GDP (Pamonsinlapatham et al., 2009). Small
GTPase proteins serve pivotal roles in linking external messages from cell surface
receptors to several downstream signaling cascades underlying a wide variety of cellular
processes including cell cycle regulation, cytoskeletal reorganization, neurite outgrowth
and differentiation (Crespo and Leon, 2000; Malumbres and Pellicer, 1998; Huang and
Reichardt, 2003).
Although several evidences have documented a correlation between RasGrfs
action downstream of Trk (MacDonald et al., 1999; Robinson et al., 2005) or G-protein
coupled receptors to the activation of Ras and Erk-MAP kinases (Baouz et al., 2001;
Mattingly and Macara, 1996; Shou et al., 1995; Zippel et al., 1996) as well as Rac
(Kiyono et al., 1999), RasGrfs have also been suggested as a missing link in the
regulation of synaptic plasticity (Brambilla et al., 1997). They act as a specific calcium
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sensor to transmit signals from the NMDA receptor to the activation of appropriate
GTPases and the induction of LTP or LTD (Li et al., 2006). It has been shown that
RasGrf1 interacts directly with the NR2B subunit of the NMDA receptor (Krapivinsky et
al., 2003), through which RasGrf1 stimulates p38/MAP kinase activation leading to an
increase in LTD. In contrast, RasGrf2 interacts with the NR2A subunit of the NMDA
receptor and activates Erk/MAP kinase leading to an increase in LTP (Li et al., 2006).
Both interactions are observed in a developmental-dependent manner, in particular after
postnatal day 20 to 25 in the mouse (Li et al., 2006). It has further been shown that
RasGrf1 promotes p38 activation by Rac in vitro while RasGrf2 activates Erk-MAP
kinase by targeting Ras-GTPases (Buchsbaum et al., 2002; Tian et al., 2004).
Further evidence supporting a role for RasGrf1 in the regulation of synaptic
plasticity, growth and development comes from studies in RasGrf1 knockout mice
(Brambilla et al., 1997; Giese et al., 2001; Itier et al., 1998; Font de Mora et al., 2003;
Clapcott et al., 2003; d'Isa et al., 2011). Although RasGrf1 knockout mice models
represent various phenotypes depending on which part of the RasGrf1gene is being
targeted, which isoforms are being blocked, and which region of brain inside the central
nervous system is being involved (Feig, 2011), it appears that full length RasGrf1
knockout (-/-) results in a severe deficit in amygdala-dependent synaptic plasticity
(Brambilla et al., 1997), as well as impairments in hippocampal-dependent plasticity
observed as failures to perform hippocampal-dependent behavioral tests such as the
Morris water maze, contextual discrimination and social transmission of food preferences
(Giese et al., 2001).
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Figure 1.4. A Schematic diagram of the RasGrf1 protein. Mouse RasGrf1, a 140kDa
protein with 1262 amino acids consist of several binding domains including a binding
domain to interact with TrkB (PH1; pleckstrin domain), and binding area with NR2B
subunit (amino acids 714-913), coiled-coil motif (CC), ilimaquinone (IQ) to bind
calmodulin, Db1 homology domain (DH) to activate Rac, the second pleckstrin domain
(PH2), Ras exchange motif (REM), cycline destruction box (CDB), and catalytic domain
(CDC25) to activate Ras. S916 is the site for RasGrf1-phosphorylation by PKA, the W1056
on RasGrf1 has been suggested as binding site for GDP-Ras, and the sequences area of
amino acids 714-913 have been described as neural domain (ND) which binds NR2B
subunit of NMDA receptor. The lower panel represents an amino acids sequence of
mouse RasGrf1 with S916 shown in red color.
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1.10 Rationale (see Figure 1.5)
1. The ability of RasGrf1 to increase neurite outgrowth has been studied in the
PC12 cells which express endogenous TrkA (Robinson et al., 2005; Yang and Mattingly,
2006). Yet the ability of RasGrf1 to induce neurite growth in BDNF-mediated TrkBexpressing cells, and whether Ras and/or Rac activation is required has not been
determined. Furthermore, while RasGrf1 is tyrosine phosphorylated in response to
neurotrophin stimulation in transfected cells in culture, the sites of phosphorylation and
whether they are essential to RasGrf1 activation has not been determined.
2. Previous data in our lab suggested that RasGrf1 is tyrosine phosphorylated in
Human embryonic kidney 293T (HEK293T) and NGF stimulated PC12 cells as well as
PC12-derived cells over-expressing TrkB. Consequently, the binding sites on both Trk
and RasGrf1 have been identified, being the HIKE domain located after tyrosine 516
(amino acids 531-542) on TrkB which binds the N-terminal PH1 domain on RasGrf1
(Robinson et al., 2005). However, the phosphorylation-dependent interaction of TrkB and
RasGrf1 has yet to be observed in primary neurons. It was also not determined whether
TrkB directly interacts with RasGrf1 or if this interaction could be mediated indirectly
through other scaffolding molecules. Scaffolding proteins are known as crucial regulators
of many key signaling pathways; they interact or bind to other members of a signaling
pathway to retain them into their complex. In this regard, post-synaptic density protein 95
(PSD95) is the intermediate candidate protein. PSD95 is a PDZ (postsynaptic density-95discs large-zona occludens-1) domain containing protein that

facilitates the

phosphorylation of NR2B by Src family kinases (Tezuka et al., 1999; Zhang et al., 2008).
PSD95 co-immunoprecipitates with TrkB and its trafficking to dendrites is facilitated by
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BDNF (Yoshii and Constantine-Paton, 2007; Ji et al., 2005). Furthermore, RasGrf1 is
enriched in post-synaptic densities and previously unpublished data in our lab showed
that PSD95 co-immunoprecipitates with NR2B in response to NMDA treatment.
3. RasGrf1 has been identified as a novel interactor of both Trk (MacDonald et
al., 1999), where it facilitates neurite outgrowth in response to low doses of NGF
stimulation in PC12 cells (Robinson et al., 2005), and the NMDA receptor, where it
facilitates LTD by activating p38-MAP kinase (Buchsbaum et al., 2002; Li et al., 2006),
and LTP through Erk-MAP kinase activation (Li et al., 2006). However, the potential of
RasGrf1, as a downstream signaling molecule, in facilitating a potential cross-talk
mechanism between the TrkB and NMDA receptors is unknown.
Thus, the present study has been designed to address the potential of RasGrf1 to
modulate both TrkB and the NMDA receptors and identify novel cross-talk mechanisms
by which the biological responses to BDNF are regulated. We have initially determined
the RasGrf1-induced neurite outgrowth in response to both NGF and BDNF in neuronallike cells as an in vitro model for primary neurons. We also examined the domain(s) and
site(s) of RasGrf1 tyrosine phosphorylation in response to BDNF stimulation in these
cells. Finally, we determined the interaction between both TrkB and NMDA receptors
with RasGrf1 in cortical/hippocampal slices, in response to BDNF and NMDA
stimulation, and provide a potential mechanism of how BDNF activation of TrkB
facilitates changes in NMDA receptor signaling.
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Figure 1.5. A schematic diagram to depict the rationales of this study. The question
marks show signaling molecules or mechanisms involved in the process which remain to
be investigated in this study. 1) The role of RasGrf1 in neurite outgrowth, the sites of
tyrosine phosphorylation and its possible downstream Ras and/or Rac-GTPase activation.
2) Possible interaction of TrkB with RasGrf1. This interaction might be directly or
indirectly through PSD95. 3) RasGrf1 signaling pathway as a candidate to mediate crosstalk between TrkB and NMDA receptors during synaptic plasticity, and also RasGrf1mediated downstream of Rac/Ras GTPases and p38/Erk MAP kinases activation.
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1.11 Hypothesis and Objectives
The general hypothesis of my thesis is that BDNF stimulates the recruitment of
RasGrf1 to TrkB thereby uncoupling RasGrf1 from the NMDA receptor and decreasing
the potential of LTD in favour of LTP. Secondly, the ability of RasGrf1 to increase
BDNF-dependent neuronal/dendritic growth may provide a second mechanism to
potentiate synaptic connections and facilitate the process of LTP. The specific objectives
of this project are as follows:
1. To determine whether the activation of RasGrf1 will increase neurite growth in
neuronal-like cells in a Ras and/or Rac-dependent manner.
2. To identify the site(s) of tyrosine phosphorylation on RasGrf1 upon BDNF stimulation.
3. To determine if BDNF stimulation couples RasGrf1 to TrkB and increases Erk-MAP
kinase activation.
4. To determine if BDNF stimulation uncouples RasGrf1 from the NMDA receptor,
decreases NMDA-induced p38-MAP kinase activation to decrease LTD in favour of
LTP.
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Chapter 2
Ras Guanine nucleotide Releasing Factor 1 (RasGrf1) enhancement of
Trk Receptor-mediated Neurite Outgrowth requires Activation of both
H-Ras and Rac
2.1 Introduction
The neurotrophin receptor tyrosine kinases, TrkA, B and C, activate diverse signaling
pathways stimulating distinct cellular responses depending on the cellular context. The
ligands for the Trk receptors are a family of related proteins termed neurotrophins and
these include nerve growth factor (NGF) which binds TrkA, brain-derived neurotrophic
factor (BDNF) which binds TrkB and neurotrophin-3 (NT-3) which binds primarily to
TrkC (Meakin, 2000; Reichardt, 2006). Upon neurotrophin binding, Trk receptors
dimerize and undergo a conformational change leading to their activation and subsequent
trans-phosphorylation on five intracellular tyrosine residues. These sites then recruit
intracellular signaling molecules essential to signal propagation. Specifically, the
signaling adaptors Shc and FRS2 competitively bind to Y499 while PLCγ1 binds to Y794
(Meakin, 2000; Reichardt, 2006; Meakin et al., 1999). In all cases, receptor bound
molecules become tyrosine phosphorylated which leads to either changes in intrinsic
enzymatic activity and/or alters the recruitment/activation of subsequent molecules
(Meakin et al., 1999).
Recently, we reported the recruitment of the brain-specific Ras-guanine nucleotide
releasing factor, RasGrf1, to activated TrkA and demonstrated that this process facilitates
neuronal process formation in PC12 cells (Robinson et al., 2005), a noradrenergic cell
line derived from a rat pheochromocytoma used extensively to investigate mechanisms of
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cell survival and differentiation downstream of growth factors and their receptors
(Greene and Tischler, 1976; Greene, 1978; Vaudry et al., 2002). Herein, we have
addressed the mechanism regulating the enhanced neurite outgrowth via small GTPases
of the Ras and Rho-family (Cdc42, Rac and RhoA) (Ridley et al., 1992; Minden et al.,
1995) which are known to serve roles in neuronal growth and differentiation (Nobes and
Tolkovsky, 1995). TrkA activation of Rac can be stimulated by one of several
mechanisms including PI3K (Soltoff et al., 1992; Wennstrom et al., 1994; RodriguezViciana et al., 1997), Ras and/or guanine nucleotide exchange factors. This leads to
inactivation of RhoA, and the release of stress fiber formation, thereby permitting the reorganization of actin that is essential to neurite outgrowth (Huang and Reichardt, 2003).
The specific guanine exchange factors that link NGF stimulated TrkA to Rac activation
include Kalirin (Chakrabarti et al., 2005) as well as RasGrf1 (Robinson et al., 2005), a
neuronal protein that is predominantly expressed in the mature brain and is essential to
learning and memory (Zippel et al., 1997; Giese et al., 2001). RasGrf1 is activated in
response to both tyrosine phosphorylation from non-receptor tyrosine kinases (Src,
Ack1), as well as serine/threonine phosphorylation downstream of protein kinase A
(Farnsworth et al., 1995; Mattingly and Macara, 1996; Kiyono et al., 2000a; Kiyono et
al., 2000b). Upon activation, RasGrf1 facilitates the exchange of GDP/GTP on Rac
through its Dbl homology (DH) domain and/or Ras through its C-terminal Cdc25
domain. Although the sites of Src-dependent tyrosine phosphorylation on RasGrf1 are not
known, this results in the activation of Rac (Kiyono et al., 2000a). In contrast, Ackdependent tyrosine phosphorylation of RasGrf1 stimulates the activation of Ras (Kiyono
et al., 2000b).
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In terms of investigating the signaling properties of RasGrf1, previous research has
shown that its co-expression with H-Ras in PC12 cells promotes constitutive neurite
outgrowth and cell soma expansion through the activation of both Ras and Rac (Yang and
Mattingly, 2006). Similarly Baldassa et al., (2007) reported that over-expression of
RasGrf1 in PC12 cells also stimulated constitutive neurite outgrowth and they suggested
that this was due to activation of Rac, not Ras, based on transfection studies in HEK cells
(Baldassa et al., 2007). In both cases, these studies addressed RasGrf1’s effect on
constitutive neurite outgrowth. In contrast, we have examined mechanisms of RasGrf1induced neurite outgrowth in response to both NGF and BDNF. Herein, we demonstrate
that neurotrophin-dependent neurite outgrowth in PC12 and TrkB-expressing nnr5 cells
(TrkB-B5) requires activation of both Ras and Rac. Moreover, we demonstrate that coexpression of RasGrf1 with H-Ras in both PC12 and TrkB-B5 cells, compensate and
mask the phenotype of function blocking RasGrf1 mutants. Lastly, we demonstrate that
the co-expression of Trk and RasGrf1 stimulates Rac activation in HEK cells consistent
with the data of Baldassa et al., (2007). However, comparable studies performed in PC12
cells reveals NGF-dependent activation of Ras, not Rac. These studies clarify the
mechanism by which RasGrf1 facilitates neurite outgrowth in response to neurotrophin
stimulation and demonstrate that RasGrf1 can stimulate different GTPases depending on
cell type.
2.2 Materials and Methods
2.2.1 Reagents. Antibodies to RasGrf1, Cdc42, GST-HRP, Trk (C-14), H-Ras, K-Ras,
and N-Ras, were from Santa Cruz. Anti-HA was from Roche. H-89 dihydrochloride
(B1427), and Mouse monoclonal β-actin antibody was from Sigma. Anti-
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phosphotyrosine (p-tyr-100) and anti-Akt (#9272) were from Cell Signaling. Anti-pan
Ras and anti-Rac1 antibodies were from Transduction Labs. Rabbit antibodies to the
carboxyl-terminal 14 residues of TrkA (1478) were prepared and affinity purified using
standard techniques (Robinson, 2008). HRP-coupled goat anti-mouse and goat anti-rabbit
secondary antibodies were from The Jackson Laboratories. NGF was from Harlan
Products for Bioscience and human recombinant BDNF was from R&D Systems. The
DC Protein Assay Kit was from Bio-Rad.
2.2.2 Plasmids. The following plasmids have been previously described: full-length
mouse RasGrf1 under control of the human elongation factor 1a promoter (pEFPRasGrf1) (Anborgh et al., 1999); pCMX-rat TrkA (wild-type and kinase-dead (KD)
[K547A]) and rat TrkB (Meakin et al., 1999), TrkA-S10 HIKE domain mutant (Robinson
et al., 2005). pEGFP was from Clontech. Dominant negative (DN) pcDNA-HA-Rac-N17,
constitutively active (CA) pcDNA-HA-Rac-G12V, pcDNA-HA-Rac, pEYFP-DN-Ras,
pEYFP-CA-Ras (G12V) were gifts of S.G. Ferguson (Robarts Research Institute).
Dominant-negative pcDNA-Cdc42-T17N, CA-Cdc42-Q61L and wild type Cdc42 (in
pcDNA) were gifts from R. Cerione (Cornell University, Ithaca, NewYork). pcDNA-HAH-Ras was the gift from J. Keller (Vanderbilt University Medical Center, Nashville, TN).
pEFP-RasGrf1-W1056E was from L. Alberghini (University of Milano, Milan, Italy) and
the RasGrf1 DH minus mutant (pMT3-PH1-IQ-Cat) was from L. Feig (Tufts University
School of Medicine, Boston, MA). The RasGrf1 S916A mutant was prepared using sitedirected mutagenesis and the mutation verified by DNA sequencing. pGex2T-cRaf-RBD
was from C. Hermann (Max Planck Institute for Molecular Physiology, Dortmund,
Germany) and pGex-PAK-CRIB was the gift of G. Pickering (Robarts Research
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Institute). The si-RNAs against Ras (sense: CCACUAUAGAGGAUUCCUACCGGAA ,
anti-sense: UUCCGGUAGGAAUCCUCUAUAGUGG) and Rac (sense: UUUGACAG
CACCGAUCUCUUUCGCC , anti-sense: GGCGAAAGAGAUCGGUGCUGUCAAA)
were from Invitrogen.
2.2.3 Cell Lines. Human embryonic kidney 293T (HEK 293T) cells were cultured under
standard conditions in DMEM with 5% supplemented calf serum (SCS) and 5% FBS
(Hyclone)

with

50

µg/ml

gentamycin

sulfate

(Sigma).

PC12

rat

adrenal

pheochromocytoma cells were maintained in DMEM with 5% SCS and 5% horse serum
(Hyclone), while TrkB-B5 (nnR5 cells stably over-expressing HA-tagged TrkB
receptors) have been described previously (Meakin, 2000; Meakin and MacDonald,
1998). These were cultured in 5% SCS and 5% horse serum in the presence of 100 µg/ml
G418 and 50 µg/ml gentamycin sulfate.
2.2.4 Immunoprecipitations and Western Blots. Transfections were performed
following standard calcium phosphate (HEK) or Lipofectamine 2000 (PC12 or TrkB-B5
cells; Invitrogen) techniques using a DNA to Lipofectamine ratio of 1:2. Basically, 1.5 x
106 cells (100 mm dish) were co-transfected with 0.5-5 µg of each indicated plasmid.
Lysates were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM
Tris, 0.5 mM EDTA, pH 8.0) containing 1 mM PMSF, 1 mM sodium orthovanadate
(NaVO4),
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immunoprecipitated with antibodies (0.5 µg anti-Trk1478, or 1 µg anti-RasGrf1), in
addition to 5 µl of washed Pansorbin (Calbiochem), at 4 oC overnight. After washing,
bound proteins were resolved on 6 or 12% SDS-PAGE and transferred to polyvinylidene
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fluoride (PVDF) membranes. Blocking prior to primary antibody incubation was
performed for 1 h at room temperature in 10 ml of 10% milk powder and Tris buffered
saline with tween-20 (TBS-T). Westerns were blotted in primary antibody at 4 oC for 16
h and then washed for 1 h in TBS-T. Westerns were then blotted in 10 ml 10% milk
powder and secondary antibody for 1 h at room temperature. Following washes in TBS-T
for 1 h, westerns were exposed to enhanced chemiluminescence (ECL) reagents and
developed.
Primary antibody dilutions are as follows: anti-RasGrf1 1:10,000; anti-Cdc42
1:2000; anti-GST-HRP 1:2000; anti-Trk (1478) (1:20,000), anti-pTyr100 (1:10,000);
anti-pan Ras (1:5000); H-Ras (1:5000); K-Ras ( 1:5000); N-Ras (1:5000) and anti-Rac1
(1:5000), anti-Akt (1:5000), anti-actin (1:20000), and anti-HA (1:5000). HRP-coupled
secondary antibodies were used at 1:10,000.
2.2.5 Neurite Response Assay and Analysis of Cell Morphology. Cells were plated
onto 50 µg/ml poly-D-lysine (Sigma) coated 30 or 100 mm dishes and transfected with
pEGFP (0.5 µg) plus Empty plasmid (1 µg), pcDNA-HA-Ras (0.5 µg), pEFP-RasGrf1 (1
µg), pEFP-RasGrf1-S916A (1 µg), pcDNA-RasGrf1-W1056E and/or pMT3-PH1-IQ-Cat (1
µg) with transfection efficiencies of 70 – 90% (Lipofectamine 2000). Fresh media and
non-saturating levels of NGF or BDNF (1 ng/ml) were added at 24 h intervals on each of
4 successive days. Inhibitor H89 (50 µM) was added before stimulation when indicated.
On each day (from day one at 24 h after transfection to day four), the percentage of EGFP
transfected cells (> 10 randomly selected fields and at least 200 cells) with neurite length
greater than 2 cell bodies diameter as well as cells that had a flattened, expanded
morphology with a width greater than 5 cell body lengths were counted using an inverted
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fluorescent microscope. Three independent neurite outgrowth experiments (n=3) were
performed and the percentage of EGFP-transfected cells extending neurites, between
samples, was statistically analyzed by One way-ANOVA with Post-Tukey test and paired
student t-test. TrkA and RasGrf1 expression and tyrosine phosphorylation was confirmed
by immunoprecipitation of 500 µg to 3.5 mg of protein, SDS-PAGE and western blotting
following the counts performed on day four. The relative densities were then statistically
analysed by paired student t-test for significant differences between samples (n=3). For
epifluorescence microscopy, cells were visualized for EGFP on inverted microscopes (1 x
70 [Olympus]; Diaphot 300 [Nikon]) at a magnification of 200X.
2.2.6 GTPase binding Assays. pGex2T-PAK-CRIB, pGex2T and GST-Raf1-RBD were
grown in 50 ml Luria broth (LB) with 50 µg/ml ampicillin for 16 h at 37 °C, added to 500
ml of LB with 50 µg/ml ampicillin and grown to an OD600 of 0.8 to 1.0. Cultures were
induced with IPTG (0.2 mg/ml) for 2 h at 37 °C, centrifuged at 5000 rpm for 10 min (4
°C), re-suspended in 10 ml 1X PBS and frozen at -80 °C. Pellets were re-suspended in 20
ml of re-suspension buffer (25 mM Tris-Cl pH 7.5, 5 mM EDTA pH 8.0, 150 mM NaCl,
1 mM PMSF, 1 µg/ml leupeptin) and the bacteria lysed by two passages through a prechilled French press at 20,000 psi. Triton X-100 was added to a final concentration of 1%
and the sample rotated for 30 min at 4 °C. The sample was then centrifuged at 14,000
rpm for 10 min at 4 °C. Washed glutathione agarose (500 µl) (Sigma) was added to the
supernatant and the mixtures incubated for 16 h at 4 °C followed by three washes with 10
ml 1X PBS and re-suspended in 250 µl interaction buffer (20 mM Hepes, 150 mM NaCl,
0.05% NP40, 10% glycerol, 1 mM PMSF, 1 µg/ml leupeptin). Laemmli sample buffer
containing 100 mM DTT was added, samples heated at 65 °C for 10 min and then
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separated by 12% SDS-PAGE along with known quantities of BSA to estimate the
amount of GST proteins isolated. HEK cells were transiently transfected with 0.5 - 5 µg
DNA using the calcium phosphate transfection method and PC12 cells were transfected
with Lipofectamine 2000. Cells were allowed to express protein for 48 h before
stimulation with NGF or BDNF (100 ng/ml) for 5 min. A control plate that was serumstarved was washed 3X with 1X PBS 24 hours before stimulation and serum-free media
added. Before stimulation, all plates were washed 3X with PBS at 1 h time points before
stimulation and incubated in serum-free media. Following stimulation, cells were
incubated for 5 min at 37 °C, followed by a wash with 10 ml PBS. Cells were lysed in
500 µl interaction buffer for 2 min and lysates centrifuged at 10,000 rpm for 10 min at 4
°C. Protein concentrations were evaluated with the DC Protein Assay Kit (BioRad). GST,
GST-PAK-CRIB or GSTRaf1- RBD (approximately 30 µg) was added to 500 µg of each
lysate and incubated at 4 °C for 16 h. Samples were pelleted at 14,000 rpm and washed
twice with NP-40 buffer. Laemmli sample buffer with100 mM DTT was added and
samples heated at 70 °C for 10 min. Proteins were analyzed on 12% SDS-PAGE and
blotted with anti-GST-HRP (1:5000), anti-Ras (1:2000) or anti-Rac (1:2000).
2.3 Results
2.3.1 Trk-dependent RasGrf1 activation facilitates GTP exchange of Rac in HEK
cells.
As RasGrf1 is a dual specificity guanine exchange factor for both Ras and Rac, we
examined which GTPase is preferentially activated downstream of Trk and RasGrf1. In
particular, RasGrf1 has been shown to activate H-Ras through its Cdc25 domain and
Rac1 through its DH domain. We initially used HEK 293T cells, co-transfected with
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TrkA and RasGrf1 and stimulated with NGF, due to their ease of high efficiency
transfection. GST fused to the CRIB domain of p21-activated kinase (PAK) was used to
pull activated GTP bound Rac1 from transfected lysates (Baldassa et al., 2007; Small et
al., 2006) while GST fused to the Ras binding domain (RBD) of Raf1 was used to pull
activated Ras (Arozarena et al., 2000). As shown in Figure 2.1 (A), CA-Rac1 (lane 3)
was pulled out by GST PAKCRIB, while a DN-Rac1 (lane 2) showed no binding to GSTPAK-CRIB. GST alone was used as a control and failed to interact with Rac1 (Figure
2.1A). An additional control of cells grown under serum-free conditions 24 h before
stimulation with NGF, showed no basal level of Rac activation (lane 1). While RasGrf1,
with or without the kinase-dead TrkA, stimulates a basal level of Rac1 activation (lanes 6
and 7), there is an increase in the activation of Rac1 in the presence of wild type, NGFstimulated TrkA (lane 8). The TrkA-HIKE domain mutant (HK) has previously been
shown to not interact with or phosphorylate RasGrf1 (Robinson et al., 2005) and was
therefore used to test the specificity of this increase in Rac activation. Accordingly, in the
presence of this mutant there was a decrease in RasGrf1 activation of Rac1 compared to
cells expressing wild-type TrkA alone (compare lane 9 to lane 6). These data indicate that
Rac1 is being activated via TrkA and RasGrf1 in HEK cells. As shown in Figure 2.1B,
RasGrf1 and TrkA are expressed consistently and RasGrf1 is tyrosine phosphorylated
upon stimulation with NGF by wild-type TrkA but not the HIKE (HK) domain mutant.
As RasGrf1 is also a guanine exchange factor for Ras, HEK cells transfected with
TrkA, RasGrf1 and wild-type, CA or DN-H-Ras were also evaluated for activation of Ras
through interaction with the Raf1-Ras RBD fused to GST which binds only active, GTPbound Ras. As shown in Figure 2.1C, CA-Ras fused to yellow fluorescent protein (YFP-
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RAS-CA) bound to Raf1-RBD-GST as expected (Figure 2.1C, lane 3), while a dominantnegative construct (YFP-RAS-DN) did not (lane 2). No detectable basal level of Ras
activation was observed in cells that were serum-starved for 24 h prior to stimulation
(lane 1) or in cells maintained in serum during this period (lane 4). Unexpectedly under
these conditions, TrkA alone did not show a detectable level of Ras activation in the
presence of NGF (lane 5). RasGrf1 did however show a high basal ability to activate Ras
in the absence of activated TrkA (lane 6) and in the presence of kinase-dead TrkA (lane
7). However, cells transfected with WT-TrkA and RasGrf1 showed a decrease in active
GTP-bound Ras (lane 8). To determine whether the loss of interaction between TrkA and
RasGrf1 would abolish this decrease, cells were transfected with the TrkA-HIKE domain
mutant instead of wild-type TrkA. These cells showed activation of Ras comparable to
the TrkA-kinase dead and RasGrf1 transfected cells (lane 9). Thus co-transfection of
TrkA and RasGrf1 leads to a decrease in Ras activation in HEK cells potentially due to a
switch in activity toward another GTPase, such as Rac (Figure 2.1A) or due to a relocalization away from H-Ras upon TrkA binding. Evaluation of RasGrf1
phosphorylation by TrkA is shown in Figure 2.1D, lane 8, and its lack of phosphorylation
by kinase-dead TrkA (KD) and the TrkA-HIKE (HK) mutants are shown in lanes 7 and 9,
respectively.
While RasGrf1 can be activated downstream of the Rho family GTPase Cdc42, via
the tyrosine kinase ACK1 (Kiyono et al., 2000b), Cdc42 can in turn be activated by DH
domain containing guanine exchange factors (Baldassa et al., 2007). For these reasons,
Trk-activated RasGrf1 was also evaluated for the potential activation of Cdc42. However,
as shown in Figure 2.1E, we detected no endogenous activated Cdc42, the only GTP-
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bound Cdc42 detected being in cells transfected with CA-Cdc42 (lane 3). There appears
to be no activation downstream of TrkA or RasGrf1 singly or together (lanes 5, 8). GST
alone did not interact with Cdc42. Expression and phosphorylation of TrkA and RasGrf1
in the presence of NGF are shown in Figure 2.1F.
2.3.2 Analysis of RasGrf1 mutants, and H-Ras, in NGF-induced neurite outgrowth
in PC12 cells.
We have previously evaluated the response of PC12 cells to NGF-stimulated TrkA
and RasGrf1 and have found that these cells have enhanced neurite outgrowth in the
presence of low doses of neurotrophins (Robinson et al., 2005). The enhanced neurite
outgrowth is likely mediated through a GTPase such as Ras or Rac1, both of which
regulate differentiation in PC12 cells. In addition, RasGrf1 over-expression has also been
reported to constitutively stimulate the flattening and enlargement of the cell soma in
PC12 cells in the presence of co-transfected H-Ras (Yang and Mattingly, 2006). Yang
and Mattingly (2006) reported that the expanded cell body required RasGrf1 activation of
Rac1 and that this was dependent on the co-expression and activation of H-Ras. To
determine if NGF stimulation potentiated similar changes in the cellular morphology of
the cell soma, we co-transfected cells with RasGrf1 and H-Ras and evaluated changes in
both neurite outgrowth and soma size in response to NGF. As shown in Figure 2.2A, we
similarly observed both phenotypes in cells co-transfected with RasGrf1 and H-Ras.
Quantification of these phenotypes revealed that cells co-transfected with H-Ras and
RasGrf1 expressed a higher basal neurite outgrowth (21.6%) response that was
approximately 3-fold higher than cells expressing H-Ras alone (7%) and that addition of
NGF stimulated a minor additional increase (27.3%) in neurite outgrowth (Figure 2.2B).
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Figure 2.2C indicates the levels of Trk and RasGrf1 tyrosine phosphorylation and
expression. With respect to changes in cell soma size, we observed that co-transfection of
RasGrf1 and H-Ras also increased the number of cells with increased basal soma size to
nearly 20% of the total population as compared to control cells transfected with GFP
alone (4%). However, there was no significant increase in the percentage of cells
showing an enhanced soma size upon stimulation by NGF in either controls or cells coexpressing H-Ras and RasGrf1. The levels of Trk and RasGrf1 expression and tyrosine
phosphorylation are shown in Figure 2.2E.
To determine whether activation of either Ras, Rac or both facilitate NGF-induced
neurite outgrowth, PC12 cells were transfected with H-Ras and either wild-type RasGrf1,
a (W1056E) RasGrf1 mutant which binds GDP-Ras but does not facilitate exchange to
GTP on Ras (Vanoni et al., 1999), as well as a RasGrf1 (S916A) mutant, the site of protein
kinase A phosphorylation reported to be required for maximal induction of Rasdependent neurite outgrowth in PC12 cells (Yang et al., 2003; Baouz et al., 2001) (Figure
2.3A). Importantly, the W1056E mutant does not affect the ability of RasGrf1 to activate
Rac (Vanoni et al., 1999). Cells were stimulated with low levels of NGF (1 ng/ml) for
four days following transfection and then evaluated for neurites longer than two cell
bodies in length. As observed in Figure 2.3, RasGrf1 transfected cells showed levels of
basal neurite outgrowth in the presence of co-transfected H-Ras (23.27% ± 0.37) which is
only somewhat increased in response to NGF (27.1% ± 0.89) (Figure 2.3B). Interestingly,
we found that expression of the RasGrf1 (S916A) mutant did not affect either basal levels
of neurite outgrowth ( 22.93% ± 2.28) or those stimulated by NGF (25.93% ± 3.08 )
(Figure 2.3B). Cells transfected with the RasGrf1 (W1056E) mutant exhibited a reduction
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in neurite outgrowth (17.67% ± 0.65), albeit levels were still higher than cells transfected
with controls, and we observed a small insignificant increase (20.73% ± 2.3) in neurite
outgrowth in response to NGF. Analysis of phosphorylation and expression levels
indicated that wild-type RasGrf1, RasGrf1 (W1056E) and the RasGrf1 (S916A) mutant
were expressed and phosphorylated at similar levels by NGF-activated TrkA (Figure
2.3C).
To further determine whether PKA facilitates RasGrf1-mediated neurite outgrowth in
response to NGF, via other phosphorylation sites and/or mechanisms, PC12 cells were
co-transfected with RasGrf1 and H-Ras and then stimulated with NGF in the presence or
absence of the PKA inhibitor, H89. As shown in Figure 2.3D, we found that application
of H89 did not lead to a decrease in NGF/RasGrf1-mediated outgrowth suggesting that
PKA is not important for TrkA-dependent activation of RasGrf1 or enhanced neurite
outgrowth in PC12 cells under these conditions. Notably, H89 did not affect tyrosine
phosphorylation levels of either Trk or RasGrf1 stimulated by NGF (Figure 2.3E).
Since the Ras/Rac activation assays in HEK cells suggested that TrkA activation of
RasGrf1 resulted in activation of Rac, we next evaluated the potential that RasGrf1
activation of Rac is involved in mediating NGF-induced neurite outgrowth in PC12 cells.
Accordingly, cells were co-transfected with H-Ras and either wild-type RasGrf1 or a
mutant RasGrf1 protein that consists of the PH1 domain, coiled-coil domain and the IQ
domain fused directly to the Cdc25 domain (PH1-IQ-Cat). This mutant is missing the
second PH domain and the Dbl homology domain required for binding and facilitating
GTP exchange of Rac (Buchsbaum et al., 1996). Importantly, this mutant does not affect
the activation of H-Ras (Yang and Mattingly, 2006). Cells transfected with EGFP showed
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very low levels of outgrowth after four days, which was slightly above 5% when
stimulated with NGF (Figure 2.3F). Cells transfected with the PH1-IQ-Cat RasGrf1
mutant showed nearly a two-fold increase in the number of cells with neurites in the
absence of NGF stimulation. Previous studies using the PH1-IQ-Cat mutant revealed that
it has a slight increase in the basal activity toward Ras, although the reasons for this were
unclear (Buchsbaum et al., 1996). Interestingly, however, we found that this mutant
stimulated neurite outgrowth in the presence of NGF and while the levels were decreased
compared to wild-type RasGrf1, the difference was not statistically different (Figure
2.3F). The levels of phosphorylation and expression of TrkA, RasGrf1 and PH1-IQ-Cat
are shown in Figure 2.3G. Taken together, these studies suggest that RasGrf1 mediates
outgrowth downstream of the Trk receptor through activation of Ras, not Rac1, in
transfected PC12 cells.
2.3.3 Trk activation of RasGrf1 facilitates GTP exchange of Ras in PC12 cells.
The reduction in neurite outgrowth of the RasGrf1 mutant (W1056E) (dominantnegative for Ras activation) suggested that in PC12 cells, RasGrf1 might be an activator
of Ras instead of Rac. However, this was in contrast to our observations in HEK cells in
which we observed an increase in Rac activation but a decrease in the activation of Ras
downstream of TrkA and RasGrf1 (Figure 2.1). Thus, we performed a GTP binding assay
on lysates from PC12 cells transfected with wild-type H-Ras and RasGrf1. In these
studies, RasGrf1 transfected cells showed low levels of basal activation of Ras in the
absence of stimulation (Figure 2.4A, lane 7). This agrees with our observations of neurite
outgrowth following co-transfection with H-Ras and RasGrf1 (Figure 2.3). However,
PC12 cells transfected with RasGrf1 and H-Ras, and stimulated with NGF, showed a
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considerable enhancement of active GTP-bound Ras (Figure 2.4A, lane 8). This
activation was comparable to that seen in the positive control lane which expressed CARas (lane 4). This also agrees with our neurite outgrowth studies in PC12 cells, but
contrasts with the decreased Ras activation observed in HEK cells suggesting that there
may be different mechanisms of NGF/TrkA and RasGrf1 signaling occur in the two cell
types. NGF-dependent Trk and RasGrf1 phosphorylation and expression levels of both
proteins are shown in Figure 2.4B.
2.3.4 Trk activation of RasGrf1 does not stimulate increased Rac activation in PC12
cells.
Yang and Mattingly (2006) indicated that Ras activation by RasGrf1 promotes
neurite extension in PC12 cells, but also increases RasGrf1 activity toward Rac. Given
this data and the Rac activation observed in HEK cells, a GTP binding assay for Rac1
was also performed in PC12 cells. PC12 cells were co-transfected with RasGrf1 plus WT
Rac1 as well as CA or DN forms of Rac1 as positive and negative controls. As shown in
Figure 2.4C, the negative control (DN-Rac1) did not interact with GST-PAK-CRIB (lane
3) while the CA-Rac1 did (lane 4) relative to GST alone. We observed a small increase in
Rac activation in NGF stimulated, un-transfected cells (lane 6) and a larger increase in
un-stimulated cells following transfection with RasGrf1 (lane 7) suggesting that RasGrf1
over-expression can intrinsically activate Rac. However, we found no discernable
increase in Rac1 activation in RasGrf1 transfected cells following NGF stimulation above
the effect of RasGrf1 alone (lane 8). Whole cell lysates were evaluated to verify
expression of Rac1 as well as to verify expression of RasGrf1 and TrkA and their
tyrosine phosphorylation status upon NGF-stimulation (Figure 2.4D).
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2.3.5 PC12 and TrkB-B5 cells express endogenous H-Ras.
Our initial experiments indicated that RasGrf1 stimulates NGF-induced neurite
outgrowth in PC12 cells via a Ras, but not Rac-dependent mechanism (Figure 2.3),
consistent with our subsequent observation that NGF stimulates an increase in RasGrf1dependent activation of Ras in PC12 cells (Figure 2.4). However, we were puzzled with
the observation that the dominant negative RasGrf1 mutant (W1056E) continued to show
high basal levels of neurite outgrowth in PC12 cells (Figure 2.3) suggesting that either
another NGF-dependent pathway was also stimulating neurite outgrowth and/or that the
over-expression of H-Ras was compensating for a loss of function phenotype. The
original decision to co-transfect RasGrf1 mutants with H-Ras was based on the
observation by Yang and Mattingly that PC12 cells don’t express endogenous H-Ras
(Yang and Mattingly, 2006). However, when testing our PC12 and TrkB-B5 cells, we
found that they do express endogenous H-Ras, but not K-Ras or N-Ras, to levels
comparable to those observed in brain (Figure 2.5). Thus, to determine whether H-Ras
over-expression was overcoming the effect of one or more of the RasGrf1 mutants, all
mutants were re-tested for their ability to support neurotrophin-induced neurite outgrowth
in the absence of ectopic H-Ras expression. Since RasGrf1 is primarily expressed in the
brain and is co-expressed predominantly with TrkB, these studies were addressed (as
described below) in TrkB-B5 cells. We previously generated this cell line from the PC12derived cell line, nnR5, that do not express TrkA (Greene and Tischler, 1976), that we
engineered to stably over-express TrkB (Meakin and MacDonald, 1998).
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2.3.6 BDNF activation of TrkB also stimulates RasGrf1-dependent enhancement of
neurite outgrowth via both Ras and Rac.
Consistent with our observation that RasGrf1 facilitates NGF-dependent neurite
outgrowth in PC12 cells, we found that BDNF-dependent TrkB activation of neurite
outgrowth is also significantly enhanced. As shown in Figure 2.6, RasGrf1 expression
stimulates an enhancement of BDNF-induced neurite outgrowth compared to unstimulated cells and un-transfected cells stimulated with BDNF. We then assayed the
RasGrf1 mutants for changes in BDNF-induced neurite outgrowth, in the absence of HRas co-expression, and as shown in Figure 2.6, both the W1056E and PH-IQ-CAT mutants
showed a reduction in BDNF-induced neurite outgrowth while the S916A mutant still
appeared to support significant neurite outgrowth. These observations were next
quantified in triplicate experiments in the absence and presence of exogenous H-Ras
expression. As shown in Figure 2.7A, we find that wild type RasGrf1 and the S196A
mutant show a basal level of neurite outgrowth (11.13% ± 1.87 and 9.86% ± 0.88
respectively) in the absence of BDNF and a significant increase in the percentage of cells
showing neurite outgrowth (20.13% ± 2.48 and 16.67% ± 1.68 respectively) in presence
of BDNF. Wild type RasGrf1 and S916A mutant also showed an approximately 2-fold
increase in the average neurite length (220 µm and 247 µm) relative to negative control
of empty plasmid (110 µm) (Figure 2.7B). These results are consistent with our data in
Figure 2.3 demonstrating that phosphorylation of Ser916 is not essential to neurotrophininduced activation of RasGrf1. However, we found that both the W1056E and PH-IQ-CAT
RasGrf1 mutants significantly reduced BDNF-induced neurite outgrowth to levels
comparable to negative controls (Figure 2.7A). Interestingly, when cells were co-
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transfected with H-Ras (Figure 2.7D), we found that only the PH-IQ-CAT RasGrf1
mutant showed a decrease in BDNF-induced neurite outgrowth relative to WT RasGrf1,
to the levels were still significantly greater than controls. These observations are
consistent with the results shown above indicating that over-expression of H-Ras masks
the phenotype of the RasGrf1 mutations. Levels of RasGrf1 and transfected H-Ras
expression are shown relative to endogenous Akt or actin as loading controls (Figures
2.7C, E, F). Collectively, these results indicate that RasGrf1 can also act downstream of
TrkB receptors to enhance BDNF-induced neurite outgrowth.
2.3.7 Both Ras and Rac si-RNAs block BDNF-induced neurite outgrowth in TrkB
cells.
To further determine whether Ras, Rac or both facilitate BDNF-induced neurite
outgrowth, TrkB-B5 cells were transfected with wild-type RasGrf1 in presence of siRNAs against either Ras or Rac1, and the percentage of neurite outgrowth and the
expression level of Ras/Rac1 were determined. As shown in Figure 2.8A, while wild type
RasGrf1 significantly (26%) increased neurite outgrowth compared to the negative
control of empty plasmid (12%), both si-RNAs against Ras and Rac1 decreased neurite
outgrowth (3.7% and 4.3% respectively) relative to wild type RasGrf1. RasGrf1 cotransfection with H-Ras also increased neurite outgrowth significantly as expected.
However, it was included in this experiment as a positive control for si-Ras plasmid.
These results further support the notion that the activation of both Ras and Rac are
required for neurotrophin-induced neurite outgrowth. The expression levels of Ras and
Rac are shown in Figure 2.8B verifying that the level of Ras and Rac expression are
reduced by the si-RNAs against Ras and Rac.
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Figure 2.1. Rac/Ras/Cdc42-GTPase pull down assay in transfected HEK cells. Cells
were transfected with wild type RasGrf1plus CA, DN or WT GTPases as well as kinase
dead (KD), HIKE domain mutated (HK) or WT TrkA. Forty-eight hours posttransfection, cells were serum starved for 1 h, stimulated with 100 ng/ml of NGF for 5
min, lysed and activated GTPases precipitated with indicated GST fusion proteins.
Samples were immunoprecipitated (IP) and assayed for phosphorylation assessment by
Western blotting (IB) (Robinson, 2008) (n=3). A) Rac-GTPase activity. Lane 1 represents
a negative control plate in which cells were starved 24 h. B) Phosphorylation assessment
of RasGrf1 and Trk during Rac-GTPase activity. C) Ras-GTPase activity. D)
Phosphorylation assessment of RasGrf1 and Trk. E) Cdc42-GTPase activity. F)
Phosphorylation assessment of RasGrf1 and Trk.
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Figure 2.2. Neurite outgrowth assay of wild type RasGrf1 in PC12 cells. PC12 cells
were transfected with EGFP plus Empty-plasmid or WT-RasGrf1, in presence of H-Ras,
treated with either NGF (1 ng/ml) for 4 consecutive days or left unstimulated. The
percentage of cells with neurite length greater than two cell bodies were counted and
statistically analyzed. Samples were immunoprecipitated (IP), separated by SDS-PAGE,
and immunoblotted (IB) with indicated antibodies. Three independent neurite outgrowth
experiments were performomed (n=3). * indicates statistical significance (P-value<0.05)
of WT-RasGrf1 relative to the Empty plasmid. A) NGF treated PC12 cells co-transfected
with WT-RasGrf1 and H-Ras. Both neurite extension (A1) and soma expansion (A2) are
shown. Scale bar is 10µm. B) PC12 cells were co-transfected with WT RasGrf1 and HRas and neurite extension assessed in -/+ NGF stimulation. C) NGF induces tyrosine
phosphorylation of both Trk and RasGrf1. RasGrf1 band appeared as expected at
≈140kDa (Robinson, 2008). D) Percentage of PC12 cells co-expressing WT RasGrf1 and
H-Ras in -/+ NGF stimulation displaying enhanced soma expansion (with expansion > 5cell body) (Robinson, 2008). E) Tyrosine phosphorylation assessment for Trk and
RasGrf1during soma expansion. RasGrf1 band appeared as expected at ≈140kDa
(Robinson, 2008).
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Figure 2.3. Neurite outgrowth assay of RasGrf1-mutants in PC12 cells. PC12 cells
were transfected with EGFP plus either empty-plasmid or WT-RasGrf1 and RasGrf1mutants in the presence of H-Ras. Cells were treated with either NGF (1 ng/ml) for 4
consecutive days or left unstimulated and the percentage of cells with neurite length
greater than two cell bodies determined. Samples were immunoprecipitated and analyzed
by SDS-PAGE/Western blot with the indicated antibodies (n=3). * indicates significant
increase in neurite outgrowth (P-value<0.05) of indicated construct in the presence of
NGF relative to Empty plasmid. A) Schematic diagram of RasGrf1. RasGrf1 is a multidomain protein including PH1(Pleckstrin homology, 50 amino acids), coiled-coil motif
(CC, 57 amino acids), CaMK binding site (IQ, 88 amino acids), Db1 homology domain
(DH, 87 amino acids), pleckstrin homology domain-2 (PH2, 66 amino acids), Ras
exchange motif (REM, 83 amino acids, cyclin destruction box (CDB) and catalytic
domain (Cdc25, 75 amino acids). In addition, S916A, a PKA phosphorylation site on
RasGrf1, and the W1056E mutation are indicated. B) Percentage of cells with neurites
greater than two cell bodies in PC12 cells expressing W1056E and S916A RasGrf1 mutants.
** indicates significant decrease of W1056E relative to WT-RasGrf1. C) Phosphorylation
assessment for W1056E and S916A mutants. D) Percentage cells with neurites greater than
two cell bodies following treatment with H89 (Robinson, 2008). E) Tyrosine
phosphorylation of RasGrf1 in the presence of H89 (Robinson, 2008). F) PC12 cells were
co-transfected with the PH1-IQ-CAT RasGrf1 mutant and H-Ras -/+ NGF. Data depicts
the percentage of cell with neurite length greater than two cell bodies (Robinson, 2008).
G) Tyrosine phosphorylation of Trk and the PH1-IQ-CAT mutant. The band for this
mutant appeared as expected under ≈60kDa (Robinson, 2008).
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Figure 2.4. Ras/Rac-GTPase pull down assay in transfected PC12 cells. Cells were
transfected with CA, DN, WT Ras or Rac and/or WT-RasGrf1. Forty-eight hours posttransfection, cells were serum starved for 1 h, stimulated with 100 ng/ml of NGF for 5
min, lysed and activated GTPases precipitated with the indicated GST fusion proteins.
Samples were also immunoprecipitated (IP) and western blotted (IB) with the indicated
antibodies to assess tyrosine phosphorylation (Robinson, 2008) (n=3). A) Ras-GTPase
activity. The activation of Ras is evident in the presence of RasGrf1 after NGF
stimulation (lane 8). B) Expression and tyrosine phosphorylation of RasGrf1 and Trk in
PC12 cells in -/+ NGF stimulation. C) Rac-GTPase activity in transfected PC12 cells.
The activation of Rac1 is unchanged in the presence of RasGrf1 after NGF stimulation
(lane 8). D) Expression and tyrosine phosphorylation of RasGrf1 and Trk in transfected
PC12 cells.
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Figure 2.5. Evaluation of endogenous Ras expression in PC12 and TrkB-B5 cells.
Lysates (50 µg) from PC12 and TrkB-B5 cells were immunoblotted (IB) using antibodies
against H-Ras, N-Ras and K-Ras. Mouse brain tissue lysate was employed as a positive
control and actin (≈43kDa) served as a loading control (n=3).
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Figure 2.6. The effect of specific functional mutations on RasGrf1 on neurite
outgrowth in TrkB expressing PC12-derived cells. TrkB-B5 cells were transfected
with EGFP and either empty-plasmid, wild type RasGrf1 or the indicated RasGrf1
mutants, in the absence or presence of co-transfected H-Ras, treated with either BDNF (1
ng/ml) for 4 days or left un-stimulated (n=3). A) BDNF stimulated TrkB-B5 cells coexpressing RasGrf1-WT and H-Ras. Scale bar is 10µm. B) The effect of various RasGrf1
constructs on neurite outgrowth in TrkB-B5 cells in the presence or absence of BDNF
and without co-expression of H-Ras. Scale bar = 10µm.
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Figure 2.7. The effect of BDNF on neurite outgrowth in TrkB-B5 cells expressing
WT and mutant forms of RasGrf1. TrkB-B5 cells were co-transfected with EGFP and
either empty plasmid, WT-RasGrf1 or the indicated mutants in the absence or presence of
H-Ras, and -/+ BDNF (1 ng/ml) for 4 consecutive days, and the percentage of cells with
neurites more than two cell bodies determined. (n=3). * indicates a significant increase in
neurite outgrowth (P-value<0.05) of indicated construct compared to Empty plasmid. A)
Expression of WT-RasGrf1 and the S916A mutant resulted in a significant increase in
neurite outgrowth response. Expression of neither the W1056E, nor the PH1-IQ-CAT
mutant influenced neurite outgrowth significantly. ** indicates significant decrease of
PH1-IQ-CAT or W1056E relative to WT-RasGrf1. B) Expression of both RasGrf1 and
S916A mutant significantly increases the average length of neurites relative to controls. C)
Expression levels of RasGrf1 constructs in transfected TrkB-B5 cells. Each lane
represents 50 µg of lysate protein. The PH1-IQ-CAT mutant appeared as expected at
≈60kDa. The blot was re-probed against Akt (≈55kDa) as a loading control. D) The
percentage of cells with neurites greater than two cell body lengths in TrkB-B5 cells coexpressing H-Ras and the indicated RasGrf1 constructs in -/+ BDNF stimulation. Under
the conditions of H-Ras over-expression the W1056E and PH1-IQ-CAT mutants showed a
significant increase in neurite outgrowth. E) Expression levels of RasGrf1constructs in
TrkB-B5 cells co-transfected with H-Ras. F) Expression of endogenous (≈22kDa) and
co-transfected HA-tagged H-Ras (HA-tagged; ≈24kDa) was determined by SDSPAGE/western blot. The blot was first probed with an antibody to H-Ras, stripped and reprobed with an antibody against HA. The blot was re-probed against β-actin (≈43kDa) as
a loading control.

77

A)

B)

C)

78
Figure 2.8. The effect of BDNF-induced neurite outgrowth in TrkB-B5 cells
expressing si-RNAs against Ras and Rac. TrkB-B5 cells were co-transfected with
EGFP and either empty plasmid, or WT-RasGrf1 co-expressing with scrambled-RNA or
si-RNA against Ras or Rac, treated with BDNF (1 ng/ml) for 4 consecutive days, or left
un-stimulated and the percentage of cells with neurites length greater than two cell bodies
diameter were determined (n=3). * indicates a significant increase in neurite outgrowth
(P-value<0.05) of indicated construct in the presence of BDNF compared to Empty
plasmid, and ** indicates significant decrease of si-Ras/Rac relative to wild type
RasGrf1. A) Neurite outgrowth assay in TrkB-B5 cells in presence of Ras/Rac si.RNAs
in -/+ BDNF stimulation. Both si-RNAs against Ras and Rac reduced neurite outgrowth
significantly in comparing to RasGrf1 wild type. RasGrf1 co-expressing with H-Ras was
used as a positive control for BDNF-induced neurite outgrowth. B) Expression levels of
endogenous Ras and Rac in transfected TrkB-B5 cells only in absence of BDNF. Note
that the expression level of both Ras and Rac was reduced respectively. Expression of
endogenous (≈22kDa) of H.Ras and Rac as well as co-transfected HA-tagged H-Ras
(HA-tagged; ≈24kDa, lane 4) as positive control are evident in this blot. The blot was reprobed against β-actin (≈43kDa) as a loading control. C) A quantification diagram of the
relative intensity for endogenous Ras (left) and Rac (right) in transfected TrkB-B5 cells

only in the absence of BDNF (n=3). The blots were normalized to the level of β-actin
expression.
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2.4 Discussion
In this study, we have addressed whether RasGrf1 activates both Ras and Rac in
response to TrkA and TrkB receptors and whether one or both are essential to NGF and
BDNF-mediated neurite outgrowth in PC12 and TrkB-B5 cells. We assayed
Trk/RasGfr1-mediated activation of Ras and Rac in both HEK cells and PC12 cells and
observed a TrkA-dependent increase in the activation of Rac in HEK cells, while
activation of Ras in this context was decreased. In contrast, in RasGrf1-transfected PC12
cells, we observed the opposite response and found that NGF-induced the activation of
Ras while Rac activity was constitutive and did not appear to change in response to NGF
stimulation. By comparison, analysis of RasGrf1 potentiation of neurite outgrowth in
both PC12 and TrkB-B5 cells, and the analysis of site-directed mutants in RasGrf1,
revealed an essential role for both Ras and Rac in mediating RasGrf1’s enhancement of
neurotrophin stimulated neurite outgrowth. Our inability to detect NGF stimulation of
Rac activity in PC12 cells was surprising given that Rac activity is required for neurite
outgrowth. This may either reflect the fact that RasGrf1 was co-transfected with H-Ras in
the GTP binding assay or that the kinetics of NGF-induced activation Rac are different
than Ras and were not detected at the time point used in assay (5 min). We also found
that the neurotrophin and RasGrf1-dependent enhancement of neurite outgrowth is not
affected by the site-directed mutant S916A which has been reported as a site of PKA
phosphorylation and activation of RasGrf1 signaling in PC12 cells (Baouz et al., 2001) as
well as in neurons of the cerebral cortex (Yang et al., 2003). Moreover, the PKA
inhibitor, H89, did not affect neurotrophin-induced enhancement of RasGrf1 signaling in
the neurite outgrowth assays. Altogether, our results show a prominent role for RasGrf1
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activation of both Ras and Rac downstream of neurotrophin-activated Trk receptors that
are essential in mediating changes in cellular morphology, specifically, neurite
outgrowth.
RasGrf1 has been shown in other studies to be an activator of both Ras and Rac in
transfected HEK cells. Specifically, in HEK and Cos-7 cells, RasGrf1 activates Ras
downstream of the non-receptor tyrosine kinase ACK1, cAMP-activated PKA, calcium
and GPCR activity (Mattingly, 1999; Kiyono et al., 2000b; Yang et al., 2003).
Conversely, RasGrf1 activates Rac downstream of the non-receptor tyrosine kinase Src
(Kiyono et al., 2000a). While the specific mechanisms involved in regulating the
activation of these distinct GTPases in HEK cells have not been determined, it is possible
that the assembly of scaffolding complexes facilitated by the Trk receptor or its substrates
may also re-direct the activity of RasGrf1 away from Ras following the initial stimulation
with NGF. Specifically, RasGrf1 activity toward Rac and p38- MAP kinase, in
transfected HEK cells, has recently been shown to depend on the assembly of a complex
involving the scaffolding protein IB2/JIP2 (Buchsbaum et al., 2002). Moreover, RasGrf1
has also been shown to interact with a microtubule-destabilizing factor SCLIP (SCG10like protein) which inhibits its ability to promote Rac activation and neurite outgrowth
(Baldassa et al., 2007).
RasGrf1 has also been shown to preferentially activate H-Ras but not N or K-Ras
(Jones and Jacksonet., 1998). Different Ras subtypes are specific to differentiative or
proliferative pathways. In particular, H-Ras, but not K-Ras, signaling through the
Raf/MEK/MAPK pathway requires endocytosis and endocytotic recycling (Porat-Shliom
et al., 2008). Other Ras types also play specific roles in PC12 differentiation. For
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example, M-Ras generates sustained activation of Erk and neurite outgrowth in an NGFdependent manner (Sun et al., 2006) and RasGrf1 also interacts with M-Ras (Quilliam et
al., 1999), which is an important protein for the development of dendritic spines in
primary neuronal cultures (Harvey et al., 2008). RasGrf1 is a neuronal protein and we
have seen that it alters cellular morphology in response to NGF activated TrkA in PC12
cells (Zippel et al., 1997; Robinson et al., 2005) as well as BDNF-activated TrkB (this
study). These studies suggest that within primary neurons, TrkB-activated RasGrf1 will
serve a role in altering cellular morphology such as branching or dendritic spine density
through BDNF-dependent activation of RasGrf1 and its subsequent activation of either
H- or M-Ras.
The data presented here has noted some important differences in several published
PC12 studies regarding the importance and expression levels of H-Ras and its effect on
RasGrf1-mediated differentiation. Yang and Mattingly (2006) did not find detectable
levels of endogenous H-Ras in their PC12 cell line and did not observe differentiation in
the absence of over-expression of transfected H-Ras (Baldassa et al., 2007). In contrast,
in our studies and those by others (Baldassa et al., 2007), we both observed endogenous
expression of H-Ras and that over-expression of RasGrf1 itself could induce a basal level
of neurite outgrowth in the absence of NGF. Moreover, we found that co-expression of
H-Ras with RasGrf1 in PC12 cells stimulated the basal neurite outgrowth response and
completely eliminated the ability to detect an essential role for Rac in neurotrophininduced neurite outgrowth. While Baldassa et al., (2007) observed a specific requirement
for Rac activation by RasGrf1 in mediating constitutive neurite extension in PC12 cells,
Yang and Mattingly (2006) observed a requirement for H-Ras co-expression and
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activation and reported no role for Rac in this process. Instead, they suggested that the
expansion in soma size in co-transfected cells was dependent on Rac activity (Yang and
Mattingly, 2006). While we also observed an expansion in soma size in cells cotransfected with RasGrf1 and H-Ras, this was not observed in either PC12 or TrkB-B5
cells expressing RasGrf1 alone, in either the absence or presence of neurotrophin
stimulation. Thus, the expanded 10-fold increase in cell soma size may reflect an artifact
of H-Ras over-expression. In fact, under conditions of high levels of Ras expression,
some researchers have reported that Ras is able to directly bind and activate B-Raf and
small G proteins associated with differentiation (Kao et al., 2001).
Importantly, our study focused on NGF and BDNF-dependent RasGrf1 enhancement
of neurite outgrowth. The fact that RasGrf1 specifically alters neuritic growth in response
to both NGF and BDNF, through the activation of specific Ras family GTPases, suggests
a potential role for RasGrf1 in mediating Trk-dependent structural changes underlying
the formation of synapses or dendritic spines in neuronal cells. Such functions would
further contribute to our understanding of how TrkB and RasGrf1, both essential proteins
for learning and memory, might be mediating aspects of synaptic plasticity within the
mature brain.
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Chapter 3
A novel site of tyrosine phosphorylation on RasGrf1 guanine nucleotide
releasing factor
3.1 Introduction
Neurotrophins including nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF), neurotrophin 3 (NT3) and neurotrophin 4/5 (NT4/5) initiate their biological
functions in part by binding to the Trk family of receptor tyrosinse kinases (Meakin,
2000; Reichardt, 2006). Upon neurotrophin binding, the two receptor subunits dimerize,
resulting in tyrosine-autophosphorylation in the intracellular kinase domain. The major
sites of phosphorylation on rat TrkA include tyrosine 499, 679, 683, 684, and 794.
Tyrosine residues 679, 683 and 684 form part of the activation loop of the kinase while
tyrosine 499 and 794 serve as docking sites for intermediate signaling (adaptor)
molecules (Hanks et al., 1988; Ibanez, 1993; Heldin, 1995; Hubbard, 1997), including
Collagen homology domain (Shc) family proteins and Fibroblast growth factor Receptor
Substrate 2 (FRS2) both of which compete to bind Tyr499 and phospholipase Cγ-1 (PLCγ1) which binds to Tyr794 (Stephens et al., 1994; Meakin et al., 1999; Minichiello, 2009).
Through these adaptor molecules, Trk is able to activate three major signaling pathways
including the Ras-mitogen activated protein kinase (Ras-MAPK) pathway underlying cell
proliferation and differentiation, the phosphotidylinositol-3 kinase (PI3K)-Akt pathway
promoting cell survival, and the phospholipase Cγ-1-Ca2+ pathway leading to synaptic
plasticity (Reichardt, 2006; Minichiello, 2009).
Although several previous studies suggest that Sos exchange factor couples
tyrosine kinase signaling pathway to the activation of Ras, and brain-specific guanine
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nucleotide exchange factor, RasGrf1, couples G-protein signals to the activation of Ras
(Buday and Downward, 1993; Egan et al., 1993; Shou et al., 1995; Zippel et al., 1996;
Mattingly and Macara, 1996; Mattingly, 1999), a large body of evidence have indicated
that Trk can also recruit RasGrf1 to promote neurite outgrowth and differentiation in
PC12 cells (MacDonald et al., 1999; Ciccarelli et al., 2000; Robinson et al., 2005; Yang
et al., 2003; Yang and Mattingly, 2006).
Ras guanine nucleotide exchange factors, namely RasGrfs (Shou et al., 1992),
previously known as CDC25Mm (Martegani et al., 1992; Wei et al., 1992) belong to a
family of guanine nucleotide exchange factors (GEFs), and present in two forms of 140
kDa-RasGrf1 which is highly expressed in the nervous system particularly in the cortex,
hippocampus and hypothalamus (Zippel et al., 1997; Sturani et al., 1997), and 130 kDaRasGrf2 which shows a high sequence homology to RasGrf1 (80%), and is expressed
ubiquitously, but is also present within mature brain (Fam et al., 1997; Anborgh et al.,
1999).
Structurally, RasGrf1 is a multi-domain protein (Figure 3.1) including a pleckstrin
homology (PH) domain in the N-terminus, a coiled coil (CC) and IQ motif, a Db1
homology domain (DH), a REM motif, a cyclin destruction box (CDB) and a cell
division cycle 25 (CDC25) domain at the C-terminus. The PH domain is necessary for
RasGrf1 localization to the plasma membrane (Buchsbaum et al., 1996), and has been
suggested to bind to phosphoinositides and other types of phospholipids in the membrane
(Harlan et al., 1994; Lemmon and Ferguson, 2000; Varnai et al., 2002). In addition, the
PH domain may also serve as a putative phosphotyrosine binding (PTB) domain (Balla,
2005; Cowburn, 1997), and bind to βγ subunits of G protein-coupled receptors (Touhara
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et al., 1994; Shou et al., 1995; Mattingly and Macara, 1996; Zippel et al., 1996). This
domain also interacts with receptor tyrosine kinases through its HIKE motif (Robinson et
al., 2005). Coiled coil domains play a role in protein-protein interaction in cooperation
with PH1 and IQ domains. The IQ domain interacts with calmodulin, and in response to
calcium elevation, RasGrf1 is activated by binding of calcium/calmodulin to the Nterminal IQ motif (Buchsbaum et al., 1996; Farnsworth et al., 1995). The DH domain
binds the Rho family of GTPases, in particular Rac1, and promotes guanine nucleotide
exchange activity toward Rac1 (Freshney et al., 1997; Kiyono et al., 1999; Innocenti et
al., 1999). The REM motif plays a role in stabilization of the core CDC25 domain, and
CDB (or PEST) is a region rich in proline, glutamic acid, serine and threonine (PEST)
amino acids, that constitutes a hypothetical target for proteolysis, an additional
mechanism to regulate the cellular level of RasGrf1 protein (Rogers et al., 1986; Baouz,
et al., 1997;; Gnesutta et al., 2001). Lastly, the CDC25 domain facilitates the activation of
Ras-GTPases (Tian and Feig, 2001; Cen et al., 1993; Wei et al., 1994).
A role for RasGrf1 is to promote the exchange of GDP for GTP on small GTPases
such as Ras and Rac, acting as a molecular switch between active GTP-bound and
inactive GDP-bound states (Tian et al., 2004; Katoh et al., 2000). Small GTPases have a
crucial role to link external messages from the cell surface to several downstream
signaling cascades underlying a wide variety of cellular processes including cell cycle
regulation, cytoskeletal reorganization, neurite outgrowth and differentiation (Crespo and
Leon, 2000; Malumbres and Pellicer, 1998; Huang and Reichardt, 2003).
In response to upstream signaling, RasGrf1 not only undergoes serine/threonine
phosphorylation by protein kinase A (Farnsworth et al., 1995; Schmitt et al., 2005;
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Mattingly and Macara, 1996), but it has also been documented in several studies that
RasGrf1 is tyrosine phosphorylated by the non-receptor tyrosine kinase Src, leading to
the activation of Rac (Kiyono et al., 2000a) and Ack1, resulting in activation of Ras
(Kiyono et al., 2000b). RasGrf1 has also been shown to be tyrosine phosphorylated by
the Trk family of receptor tyrosine kinases (Robinson et al., 2005). However, the sites of
tyrosine phosphorylation, whether they are essential to the enhancement of neurite
outrgrowth and whether they affect the activation of either Ras or Rac-GTPases have not
been addressed.
In this study, we identified novel phosphorylation sites in the CDC25 domain of
RasGrf1, using site directed mutagenesis, and determined the level of RasGrf1 tyrosine
phosphorylation by these mutants after either NGF or BDNF stimulation. We also
examined the ability of these mutants to facilitate NGF-mediated neurite outgrowth in the
PC12 cell line, a neuronal-like model system widely used to study the mechanisms of cell
differentiation downstream of TrkA receptor as well as in PC12-derived cells, (namely
TrkB-B5) over-expressing TrkB receptors.
3.2 Materials and Methods
3.2.1 Reagents. Antibodies to RasGrf1(C-20, sc-224), Trk (C-14), anti-H-Ras and antiMyc (9E10) were from Santa Cruz. Anti-Rac1 and TrkB antibodies were from BD
Transduction Laboratories. Mouse monoclonal β-actin antibody was from Sigma. Antiphosphotyrosine (p-Tyr-100) was from Cell Signaling. Rabbit antibodies to the carboxylterminal 14 residues of TrkA (1478) were prepared and affinity purified using standard
techniques (Robinson, 2008). HRP-coupled goat anti-mouse and goat anti-rabbit
secondary antibodies were from The Jackson Laboratories. NGF was from Harlan
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Products for Bioscience and human recombinant BDNF was from R&D Systems. The
DC Protein Assay Kit was from Bio-Rad.
3.2.2 Plasmids. The following plasmids have been previously described: full-length
mouse RasGrf1 under control of the human elongation factor 1a promoter (pEFPRasGrf1) (Anborgh et al., 1999); pCMX-rat TrkA (wild-type) and rat TrkB (Meakin et
al., 1999). pEGFP was from Clontech. pcDNA-HA-H-Ras was the gift from J. Keller
(Vanderbilt University Medical Center, Nashville, TN).
3.2.3 Cell Lines. HEK 293T cells were cultured under standard conditions in DMEM
with 5% supplemented calf serum (SCS), 5% FBS (Hyclone), and 50 µg/ml gentamycin
sulfate (Sigma). PC12 rat adrenal pheochromocytoma cells were maintained in DMEM
with 5% SCS and 5% horse serum (Hyclone), while TrkB-B5 (nnR5 cells stably overexpressing HA-tagged TrkB receptors) have been described previously (Meakin, 2000;
Meakin and MacDonald, 1998). These were cultured in 5% SCS and 5% horse serum in
the presence of 100 µg/ml G418 and 50 µg/ml gentamycin sulfate.
3.2.4 Immunoprecipitations and Western Blots. Transfections were performed
following standard calcium phosphate (HEK) or Lipofectamine 2000 (PC12 or TrkB-B5
cells; Invitrogen) techniques using a DNA to Lipofectamine ratio of 1:2. Briefly, 1.5 x
106 cells per 100 mm dish were co-transfected with 0.5-5 µg of each indicated plasmid.
Lysates were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM
Tris, 0.5 mM EDTA, pH 8.0) containing 1 mM PMSF, 1 mM sodium orthovanadate
(NaVO4),
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addition to 10 µl of washed 50% slurry Pansorbin (Calbiochem), at 4 oC overnight and
were washed 3 times with fresh NP-40 lysis buffer on the next day. The bound proteins
from immunoprecipitation or whole cell lysate (WCL) were re-suspended in 25 µl
Laemmli sample buffer and heated at 65 °C for 10 min. Samples were then resolved on 612% SDS-polyacrylamide gels and transferred (5 volts, 1-2 hours) to polyvinylidene
flouride membranes (PVDF, Pall Life Sciences). Blocking prior to primary antibody
incubation was performed for 1 h at room temperature in 10 ml of 10% milk powder and
Tris buffered saline with tween-20 (TBS-T). Western Blots were incubated with primary
antibody at 4 oC for 16 h, and then washed for 1 h in TBS-T. Westerns were then blotted
in 10 ml 10% milk powder and secondary antibody for 1 h at room temperature.
Following washes in TBS-T for 1 h, westerns were exposed to enhanced
chemiluminescence (ECL) reagents and developed. Primary antibody dilutions are as
follows: anti-RasGrf1 1:10,000; anti-Trk (1478) (1:20,000), anti-TrkB (BD Transduction
Laboratories) (1:2000), anti-Myc (1:2000); anti-pTyr100 (1:10,000); anti-H-Ras
(1:5000); and anti-Rac1 (1:5000), anti-actin (1:20000). HRP-coupled secondary
antibodies were used at 1:10,000.
3.2.5 Neurite Response Assay and Analysis of Cell Morphology. PC12 or TrkB-B5
Cells were plated onto 50 µg/ml poly-D-lysine (Sigma) coated 30 or 100 mm dishes and
transfected with pEGFP (0.5 µg) plus Empty plasmid (1 µg), pcDNA-HA-Ras (0.5 µg),
pEFP-RasGrf1 (1 µg) with transfection efficiencies of 70 – 90% (Lipofectamine 2000).
Fresh media and non-saturating levels of 1 ng/ml NGF or BDNF (NGF for PC12, BDNF
for TrkB-B5) were added at 24 h intervals on each of 4 successive days. On each day
(from day one at 24 h after transfection to day four), the percentage of EGFP-expressing
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cells in >10 randomly selected fields, at least 200 cells pre field, were scored for neurite
outgrowth using an inverted fluorescent microscope (1 x 70 [Olympus]; Diaphot 300
[Nikon]) at a magnification of 200X. The percentages of green cells with a length of
neurite greater than 2 cell bodies in diameter were calculated. Three independent neurite
outgrowth experiments (n=3) were performed and the percentage of EGFP-transfected
cells extending neurites, between samples, was statistically analyzed by One wayANOVA with Post-Tukey test and paired student t-test. TrkA and RasGrf1 expression
and tyrosine phosphorylation was confirmed following the counts performed on day four,
by immunoprecipitation of 500 µg to 3.5 mg of protein or loading whole cell lysate on
SDS-PAGE gel and western blotting. The relative densities were then statistically
analysed by paired student t-test for significant differences between samples (n=3).
3.3 Results
New sites of RasGrf1 tyrosine phosphorylation were identified in this study using site
directed mutagenesis in specific RasGrf1 functional domains followed by analysing their
effect on neurotrophin-induced neurite outgrowth in PC12 cells or PC12-derived cell
lines over-expressing TrkB receptor.
3.3.1 Tyrosine residues Y95 and Y233 in the PH1-IQ domain on RasGrf1 are sites of
tyrosine phosphorylation.
Since the PH1 domain of RasGrf1 (Figure 3.1) was determined to interact with
Trk in vitro (Ciccarelli et al., 2000; Robinson et al., 2005), and the IQ domain is activated
by calmodulin (Buchsbaum et al., 1996; Farnsworth et al., 1995), the PH1-IQ region of
RasGrf1 was initially targeted by site directed mutagenesis. Within this region there were
a total of 7 potential phosphotyrosine acceptor sites (Tyr23, Tyr54, Tyr66, Tyr95, Tyr130,
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Tyr145, Tyr233) (Figure 3.2A) and while some residues were predicted to be more likely
sites of phosphorylation, a series of combinatorial mutants were generated (Fig 3-2A).
Myc-tagged RasGrf1 PH1-IQ domain constructs containing alanine substitution
mutations at these residues were then co-transfected with TrkA into HEK cells and the
level of tyrosine phosphorylation determined in response to NGF (Robinson, 2008). As
shown in Figure 3.2, among the various potential sites of tyrosine phosphorylation on
PH-IQ, it appeared the NGF stimulation increased the phosphorylation of RasGrf1 wild
type and PHIQ1, but not PHIQ2 and PHIQ3 (Figure 3.2B). Since the only difference
between PHIQ2 relative to PHIQ1 is the Y233A on PHIQ2, Y233 is suggested as a major
site of RasGrf1 tyrosine phosphorylation by NGF-mediated TrkA activation. Moreover,
these results indicate that residues Y23, Y53 and Y145 are not acceptor sites of tyrosine
phosphorylation since they were not mutated in the PHIQ2 construct and this construct
was not phosphorylated. However, residues Y66,

95, 130

could still be sites of additional

tyrosine phosphorylation as these sites were mutated in both the PHIQ2&3 constructs,
both of which were not phosphorylated. Thus, to ensure whether the level of decrease in
phosphorylation in PHIQ2 and PHIQ3 are due to only Y233 or potentially to other sites at
Y66, Y95 and/or Y130 , two other mutants were generated in the PH1 domain and tested,
namely, Y95A and Y130A (Figure 3.2A). Interestingly, the results of this experiment
revealed that the Y95A mutant in the PH1 domain reduced tyrosine phosphorylation levels
remarkably, suggesting that Y95 is also a target of NGF-dependent phosphorylation of
RasGrf1 (Figure 3.2C) (Robinson, 2008).
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3.3.2 Neurite outgrowth is independent of RasGrf1 tyrosine phosphorylation in the
PH1-IQ domains.
Given the fact that Y95 and Y233 are the major sites of tyrosine phosphorylation on
in the PH1-IQ domains in RasGrf1 in HEK cells, changes in NGF-mediated neurite
outgrowth were next evaluated for the RasGrf1-Y95/233A double mutant (called RasGrf1M2) relative to RasGrf1-WT in PC12 cells in the presence of co-transfected H-Ras
(Robinson, 2008). To ensure that these phosphorylation sites are functionally relevant,
PC12 cells were transfected with either RasGrf1 wild type or RasGrf1-Y95/233A mutant
and the percentage of cells with neurite outgrowth was assayed after NGF stimulation. As
shown in Figure 3.3A, the RasGrf1-Y95/233A mutant increased neurite outgrowth
significantly (34%) comparable to RasGrf1 wild type (38%) rather than being reduced
suggesting that Y95/233A sites of tyrosine phosphorylation are not involved in neurite
outgrowth. The level of RasGrf1 tyrosine phosphorylation of wild type and Y95/233A
mutant in PC12 cells was shown in Figure 3.3B. The RasGrf1-Y95/233A mutant appears to
remain phosphorylated in response to NGF in PC12 cells, comparable to RasGrf1 wild
type (compare lane 6 to lane 4).
3.3.3 Tyrosine Y1048A and Y1062A in CDC25 domain are involved in RasGrf1
tyrosine phosphorylation and neurite outgrowth.
Since it is well documented that RasGrf1 activates Ras by its CDC25 domain, we
next targeted this region for site-directed mutagenesis. In a study by Vanoni et al., (1999),
W1056 on RasGrf1 was suggested as a binding site for GDP-Ras-GTPase complex,
tempting us to consider that tyrosine residues around this area might be involved in
RasGrf1-mediated neurite outgrowth downstream of Trk. Thus, tyrosine residues Y1048
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and Y1062 were next targeted by site directed mutagenesis as they were predicted to be
potential sites of phosphorylation. The prediction has been made based on some criteria
such as the optimal protein-protein interaction of RasGrf1 and its cognate binding
proteins, the primary group sequences surrounding these phosphoresidues, and spatial
configuration for the accessibility of phosphoresidues to be able to predict the location of
these phosphorylation sites. This new mutant was made from the previous RasGrf1 triple
mutant (Y95/130/233A) that had been shown to contain major sites of RasGrf1 tyrosine
phosphorylation in the PH1 and IQ domains (Robinson, 2008). Since RasGrf1 is
expressed primarily in the brain accordingly with TrkB, neurite outgrowth for RasGrf1WT and its mutants were further addressed in TrkB-B5 cells. Thus to ensure that these
phosphorylation sites, and their effect on neurite outgrowth are functionally relevant,
TrkB-B5 cells were transfected with RasGrf1-WT and the RasGrf1-M3/M5 mutants in
the absence of co-transfected H-Ras. As mentioned earlier (Chapter 2), the original idea
of using H-Ras in PC12 cell study was based on the observation by Yang and Mattingly
(Yang and Mattingly, 2006) that PC12 cells don’t express sufficient endogenous H-Ras.
However, at the time of the current experiments, we discovered that both our PC12 and
TrkB-B5 cells do express endogenous H-Ras. As shown in Figure 3.4B, while RasGrf1WT and Y95/130/233A mutant (RasGrf1-M3) demonstrated significant increase (both
approximately 16%) in neurite outgrowth in comparison to empty plasmid (4%), the level
of neurite outgrowth was reduced significantly by the RasGrf1-Y95/130/233/1048/1062A mutant
(RasGrf1-M5) (11%) relative to RasGrf1 wild type, implicating Y1048 and Y1062 are
primary sites of tyrosine phosphorylation that are important for neurotrophin-mediated
neurite outgrowth. However, since the RasGrf1-M5 mutant still demonstrated neurite
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outgrowth that is still significantly increased relative to the negative control (empty
plasmid), it is possible that there are potentially additional tyrosine phosphorylation sites,
within the DH domain, that are involved in neurite outgrowth. The level of RasGrf1
phosphorylation is shown in Figure 3.4C as well as the relative density in right panel.
While RasGrf1-WT is phosphorylated in response to BDNF, the level of tyrosine
phosphorylation is significantly (nearly 2-fold) decreased compared to RasGrf1-WT, but
still detectable, in the RasGrf1-M5 mutant.
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Figure 3.1. A schematic diagrams of RasGrf1 protein. Mouse RasGrf1, a 140kDa
protein with 1262 amino acids consists of several binding domains including a binding
domain to interact with TrkB (PH1; pleckstrin domain), and a region that binds with the
NR2B subunit (amino acids 714-913), coiled-coil motif (CC), ilimaquinone (IQ) domain
to bind calmodulin, Db1 homology domain (DH) to activate Rac, the second pleckstrin
domain (PH2), Ras exchange motif (REM), cycline destruction box (CDB), and the
catalytic domain (CDC25) to activate Ras. S916 is the site for RasGrf1-phosphorylation by
PKA, the W1056 on RasGrf1 has been suggested as binding site for GDP-Ras, and the
sequence area encoding amino acids 714-913 have been described as a neural domain
(ND) which binds the NR2B subunit of NMDA receptor. The lower panel represents an
amino acids sequence of mouse RasGrf1 with S916 shown in red color.
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Figure 3.2. Tyrosine phosphorylation analysis of RasGrf1-PHIQ domains mutants
in HEK cells. Tyrosine phosphorylation levels of RasGrf1 after site directed mutagenesis
of tyrosine (Y) to alanine (A) in the PH1-IQ domain (Robinson, 2008) (n=3). A) A
schematic diagram of RasGrf1 presenting the tyrosine mapping in PH1-IQ domains and
different provided mutants. RasGrf1 contains 7 tyrosine sites in PH1 to IQ domains
including tyrosine 23, 53, 66, 95, 130, 145, and 233. B) The level of tyrosine
phosphorylation of RasGrf1 wild type (PHIQ-WT) and its point mutants including
PHIQ1, PHIQ2, and PHIQ3 in HEK cells in respond to NGF. Note that Y233 involves in
RasGrf1 tyrosine phosphorylation. C) The level of tyrosine phosphorylation in PH1-Y95A
and PH1-Y130A point mutants. Note that Y95 appeared to be a site of tyrosine
phosphorylation.
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Figure 3.3. Neurite outgrowth assay of RasGrf1 wild type versus Y95/233A mutant
in PC12 cells. PC12 cells were transfected with EGFP plus Empty-plasmid or RasGrf1WT/M2 mutant, in presence of H-Ras, treated with either NGF (1 ng/ml) for 4
consecutive days or left un-stimulated. The percentage of cells with neurite length greater
than two cell bodies in diameter were counted and statistically analyzed. Samples were
immunoprecipitated (IP), separated by SDS-PAGE, and immunoblotted (IB) with
indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of RasGrf1WT/M2 in presence of NGF relative to the Empty plasmid (Robinson, 2008). A) NGFmediated TrkA neurite outgrowth assay of RasGrf1 wild type (RasGrf1.WT) and the
RasGrf1-Y95/233A mutant in PC12 cells co-transfected with H-Ras. RasGrf1-Y95/233A
mutant did not reduce neurite outgrowth relative to negative control. B) The level of
tyrosine phosphorylation of RasGrf1 wild type and Y95/233A mutant in PC12 cells in
response to NGF. Note that RasGrf1-M2 appeared to be still phosphorylated.
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Figure 3.4. Neurite outgrowth assay of RasGrf1 wild type versus RasGrf1-CDC25
domain mutant in TrkB-B5 cells. TrkB-B5 or HEK cells were transfected with EGFP
plus Empty-plasmid or RasGrf1-WT/M3/M5 mutants (and TrkB construct for HEK cells
only), treated with either BDNF (1 ng/ml) for 4 consecutive days or left un-stimulated.
The percentage of cells with neurite length greater than two cell bodies in diameter were
counted and statistically analyzed. Samples were immunoprecipitated (IP), separated by
SDS-PAGE, and immunoblotted (IB) with indicated antibodies (n=3). * indicates
statistical significance (P-value<0.05) of indicated construct in presence of BDNF
relative to the Empty plasmid, and ** indicates significant decrease of RasGrf1-M5
relative to wild type RasGrf1. A) A schematic diagram of RasGrf1 presenting the
tyrosine mapping in CDC25 domain as well as different provided mutants including
RasGrf1-Y95/130/233A

(RasGrf1-M3)

mutant

in

PHIQ

domain

and

RasGrf1-

Y95/130/233/1048/1062A mutant (RasGrf1-M5). RasGrf1 contains 10 tyrosine sites in CDC25
domain including tyrosine 1048, 1062, 1067, 1115, 1178, 1182, 1196, 1225, 1236, and
1250. B) Neurite outgrowth assay of RasGrf1 wild type (RasGrf1-WT) and various point
mutants including triple mutant of RasGrf1-M3 and RasGrf1-M5 mutants in TrkB-B5
cells in respond to BDNF. RasGrf1-M5 mutant reduced neurite outgrowth significantly
relative to RasGrf1-WT. C) The level of tyrosine phosphorylation in RasGrf1-WT and its
M3 and M5 mutants in HEK cells. RasGr1-M5 significantly decreased the level of
RasGrf1 phosphorylation. A quantification diagram of the relative density for the level of
tyrosine phosphorylation is shown in right panel (n=3). The blots were normalized to the level of
RasGrf1 protein expression.
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3.4 Discussion
In this study we have addressed novel sites of Trk-induced tyrosine
phosphorylation in RasGrf1. Although some studies have indicated tyrosine
phosphorylation of RasGrf1 (Kiyono et al., 2000a&b) downstream of Trk (Robinson et
al., 2005), the specific site(s) of tyrosine phosphorylation on RasGrf1 have not yet been
determined. The results here provide evidence about the properties of several tyrosine
phosphorylation sites in different domains of RasGrf1 including the PH, IQ and CDC25
domains. These domains have been selected based on a previous study, which
demonstrated that PH and IQ domains are involved in both the interaction between Trk
and RasGrf1, and in the level of RasGrf1-tyrosine phosphorylation (Robinson et al.,
2005). Furthermore, Ras activation (compared to Rac1) has been suggested as a
prominent event for neurotrophin-dependent neurite extension downstream of RasGrf1CDC25 domain (Yang and Mattingly, 2006; Chapter 2).
Firstly, while the PH1 domain of RasGrf1 is the major site of interaction between
Trk and RasGrf1 (Ciccarelli et al., 2000; Robinson et al., 2005) and we find that it is in
fact tyrosine phosphorylated in response to Trk activation, these sites of phosphorylation
are not required during NGF-mediated neurite outgrowth in PC12 cells. The IQ domain
of RasGrf1 also did not appear to be a site of tyrosine phosphorylation of RasGrf1 during
NGF-mediated neurite outgrowth, although this domain has been indicated to cooperate
with the PH domain in the interaction between Trk and RasGrf1 (Robinson et al., 2005).
This result was expected as the IQ domain was suggested to bind calcium/calmodulin
kinases in response to calcium (Buchsbaum et al., 1996; Farnsworth et al., 1995), by
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which RasGrf1 undergoes serine phosphorylation at residue 916 (Farnsworth et al., 1995;
Schmitt et al., 2005).
Secondly, we demonstrate that specific tyrosine sites in the CDC25 domain are
critical for tyrosine phosphorylation of RasGrf1 during neurotrophin-mediated neurite
outgrowth. Specifically, tyrosine 1048 and/or tyrosine 1062 appear to be crucial for
neurotrophin-dependent RasGrf1 tyrosine phosphorylation as well as enhanced neurite
outgrowth. Further study is required to understand whether one or both tyrosine sites are
necessary for RasGrf1 tyrosine phosphorylation. To answer this question, site directed
mutagenesis of only Y1048A or Y1062A is recommended for future study. Interestingly,
both tyrosine sites are located approximately beside Tryptophan 1056 (W1056), a site that
has been indicated to be crucial for binding of RasGrf1 to Ras-GTPase (Vanoni et al.,
1999). It is possible that these phosphorylation sites cooperate with W1056 to bind and/or
activate Ras-GTPases.
Furthermore, in this study, the level of neurite outgrowth in RasGrf1-M5 still
appeared to be slightly higher (nearly 2-fold) than negative control, and the level of
reduction in tyrosine phosphorylation of RasGrf1-M5 is not completed, suggesting that
other tyrosine residues might be involved in RasGrf1 tyrosine phosphorylation to
maximize neurotrophin-mediated neurite outgrowth. RasGrf1 is also tyrosine
phosphorylated by Src, which leads to the activation Rac (Kiyono et al., 2000a),
suggesting that the DH domain of RasGrf1, the domain for Rac activation, might be a site
of RasGrf1 tyrosine phosphorylation during neurotrophin-mediated neurite outgrowth.
Since only the PH, IQ and CDC25 domains were investigated in this study, tyrosine
phosphorylation sites in the DH domain of RasGrf1 remain to be investigated. In this
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regard, the DH domain has eight tyrosine sites: Y259, Y308, Y337, Y346, Y367, Y384, Y392,
and Y415, two of which (Y259 and Y415) have been predicted to be sites of tyrosine
phosphorylation and can be targeted by site directed mutagenesis in future studies. It
would be also interesting to use this mutant construct to investigate RasGrf1-mediated
GTPase activity in vitro in PC12 cells and in vivo in primary neuronal cultures to
understand how tyrosine phosphorylation co-ordinates RasGrf1 toward either Ras or Rac
activation.
Collectively, these data suggest a novel site of tyrosine phosphorylation within the
CDC25 domain of RasGrf1 during neurotrophin-mediated neurite outgrowth, and that
Y1048 and/or Y1062 are crucial for neurotrophin-mediated neurite outgrowth through
RasGrf1 downstream of Trk receptors.
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Chapter 4
RasGrf1 cross talks between TrkB and NMDA receptors
4.1 Introduction
The high affinity tropomyosin-related kinases (Trk), including TrkA, B and C, are
receptors for a family of closely related growth factors collectively termed the
neurotrophins. These neurotrophins include nerve growth factor (NGF) which binds
TrkA, brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4) which bind
TrkB, and neurotrophin 3 (NT3) which binds TrkC respectively (Meakin, 2000;
Reichardt, 2006). The Trk receptor tyrosine kinases function primarily in the regulation
of pathways involved in neuronal differentiation and survival. Of particular relevance to
my thesis, TrkB regulates synapse development and plasticity in the central nervous
system in addition to the mechanoreceptive sensory neurons in the peripheral nervous
system (Reichardt, 2006; Kaplan and Miller, 2000; Huang and Reichardt, 2001).
The TrkB receptor is expressed widely on both presynaptic and postsynaptic
membranes of the nerve terminal and dendritic spines inside the brain including the
cortex and hippocampus. Accordingly, in addition to its well known effects on neuronal
outgrowth and differentiation, BDNF-mediated TrkB activation is crucial in various
aspects of synaptic plasticity and modulates dendritic branches and spine formation in the
entire brain including the cortex, hippocampus, cerebellum and amygdala (Carvalho et
al., 2008; Lu et al., 2008; Amaral et al., 2007; Minichiello, 2009).
By indirectly modulating the N-methyl-D-aspartate (NMDA) receptor, BDNF
contributes in the regulation of the molecular processes of learning and memory namely
long-term potentiation (LTP) and long-term depression (LTD) (Wu et al., 2004; Xu et al.,
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2006; Kang et al., 1997; Akaneya et al., 1997; Lessmann and Heumann, 1998; Levine
and Kolb, 2000; Li et al., 1998). The evidence for a role of BDNF-mediated TrkB
activation of LTP comes from the fact that any deletion in the Bdnf or trkB genes, in vivo
blocking of BDNF binding to TrkB and/or pre-treating hippocampal slices with TrkB
antiserum, has been found to either impair or significantly reduce the induction of LTP
(Reichardt, 2006; Minichiello, 2009). LTP can be observed in the hippocampus, and also
in other neural structures including the cerebral cortex, cerebellum and amygdala (Bauer
et al., 2002; Nakazawa et al., 2006; Minichiello, 2009). Furthermore, LTP is dependent or
independent of the NMDA receptor. However, the NMDA receptor-dependent model of
LTP has been widely studied in the hippocampal area (Lisman, 2003).
The NMDA receptor is an ionotropic channel that upon activation by in vivo
glutamate or in vitro NMDA, allows the intracellular flow of Na+, and to a lesser extent
Ca2+, as well as extracellular flow of K+. Structurally, it is a heterotetrameric complex
made up of two obligatory NR1 subunits, and two modulatory NR2 (A-D) subunits which
control the electrophysiological properties of the NMDA receptor (Kutsuwada et al.,
1992; Monyer et al., 1992; Paoletti, and Neyton, 2007; Kohr, 2006). Although the
NMDA receptor contributes to both LTP and LTD, several studies suggest that the NR2A
subunits of the NMDA receptor contribute to LTP whereas the NR2B subunits promote
LTD (Li et al, 2006; Kollen et al., 2008; Liu et al., 2004; Massey et al., 2004).
The cell surface localization of the NMDA receptor is regulated by clathrinmediated endocytosis in which the 1472YEKL motif on the NR2B subunit serves a critical
role in this internalization. It has been shown that phosphorylation of tyrosine 1472
(Tyr1472) in the YEKL motif by Src family kinases uncouples the receptor from clathrin-
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mediated endocytosis and increases the cell surface retention and activity of the NMDA
receptor (Nakazawa et al., 2001; Prybylowski et al., 2005).
Although the mechanism by which BDNF regulates NMDA receptor-mediated
neural plasticity is largely unknown, it appears that BDNF activation of TrkB modulates
the tyrosine phosphorylation of the NR2B subunit of the NMDA receptors through which
increases the retention of the receptors on the postsynaptic cell surface (Nakazawa et al.,
2001; Prybylowski et al., 2005). As a result of prolonged surface retention of the NMDA
receptor, and responding to L-glutamate, the intracellular calcium levels increase in the
postsynaptic neuron (Minichiello, 2009; Lin et al., 1998; Levine et al., 1998; Levine and
Kolb, 2000). Increases in the Ca2+ influx in postsynaptic neurons results in the activation
of a number of signaling molecules including protein kinase C (PKC), protein kinase A
(PKA) and calcium calmodulin-activated kinases (CaMKII and IV) (Ghosh and
Greenberg, 1995; West et al., 2001) leading to the initiation of signaling cascades that
underlie neuronal development and synaptic plasticity (Li et al., 2006; Minichiello,
2009).
Among these kinases, PKA and CaMKII have been suggested to activate a Ras
Guanine nucleotide exchange factor (RasGrf1)-dependent signaling pathway (Farnsworth
et al., 1995) through phosphorylation of serine 916 (S916) on RasGrf1 (Schmitt et al.,
2005), and tyrosine-phosphorylation, at unknown sites, through non-receptor tyrosine
kinases such as Src (Kiyono et al., 2000a) or the Cdc42-GTPase-dependent of the kinase
Ack1 (Kiyono et al., 2000b).
Ras-Guanine nucleotide Releasing Factors (RasGrfs) consist of two forms:
RasGrf1 (140 kDa) which is highly expressed in the nervous system (Zippel et al., 1997),
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and RasGrf2 (130 kDa), which shows a high degree of sequence homology (80%) to
RasGrf1, and is expressed ubiquitously, but is also present within the mature brain (Fam
et al., 1997; Anborgh et al., 1999). RasGrfs have been suggested to be a missing link in
the NMDA receptor regulation of synaptic plasticity. They act as a specific calcium
sensor to transmit signals from the NMDA receptor to the activation of appropriate
GTPases and the induction of LTP or LTD (Li et al., 2006).
It has been suggested that RasGrf1 interacts directly with the NR2B subunit of the
NMDA receptor (Kraivinsky et al., 2003), through which RasGrf1 stimulates p38/MAP
kinase activation leading to an increase in LTD. In contrast, RasGrf2 interacts with the
NR2A subunit of the NMDA receptor and activates Erk/MAP kinase leading to an
increase in LTP. However, both interactions are observed in a developmental-dependent
manner, in particular after postnatal day 20 to 25 in the mouse (Li et al., 2006). It has
been further shown that RasGrf1 promotes p38 activation by Rac in vitro while RasGrf2
activates Erk-MAP kinase by targeting Ras-GTPases (Buchsbaum et al., 2002; Tian et al.,
2004).
We have previously identified RasGrf1 as a novel substrate of Trk to facilitate
neurite outgrowth in response to low doses of NGF stimulation in PC12 cells and BDNF
stimulation in PC12-derived cells overexpressing TrkB namely TrkB-B5 cells (Robinson
et al., 2005; Chapter 2). In this study, the potential of RasGrf1 to co-ordinate the
activation and function of both TrkB and NMDA receptors was addressed using cortical
and hippocampal slices from postnatal-30 adult mice. Furthermore, the interactions
between the NR2B subunit and TrkB with RasGrf1 were determined, and the changes in
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activation of Erk and p38 MAP kinase were characterized in response to BDNF and/or
NMDA stimulation.
4.2 Materials and Methods
4.2.1 Reagents.
The anti-RasGrf1 (C-20, sc-224), anti-RasGrf2 (sc-7591), anti-Trk (sc-11), anti-NMDA
NR2B (NMDAε2 sc-1469), anti-NMDA NR2A (NMDAε1 sc-9056), anti-PSD95 (7E3,
sc-6926), anti-Shc (sc-28883), normal mouse IgG (sc-2343), normal rabbit IgG (sc- 2027
and normal goat IgG (sc-2028) antibodies were from Santa Cruz. The anti-TrkB mouse
antibody #1494 was from (BioVision). Mouse anti-TrkB monoclonal antibody (610102),
anti-ShcC (#610643) and anti-RasGrf2 (#610840) antibodies were from Transduction
Labs. Rabbit anti-Trk antibodies (Trk1478) to the carboxyl-terminal 14 residues of TrkA
were prepared and affinity purified using standard techniques (Robinson, 2008). Antiphosphotyrosine (p-Tyr-100, #9411S), anti-phospho-p38 MAP Kinase (Thr180/Tyr182,
#9211S), anti-p38 MAP Kinase (9212), anti-phospho-Erk p44/42 (Thr202/Tyr204,
#9106S) and anti-Erk p44/42 MAP Kinase (#9102) antibodies were from Cell Signaling.
HRP-coupled goat anti-mouse, rabbit anti-goat and goat anti-rabbit secondary antibodies
were from Jackson Laboratories. Human recombinant BDNF was obtained from R & D
Systems and used at a concentration of 100 ng/ml final. NMDA (M3262) was used at a
final concentration of 100 µM and was from Sigma. NMDA was used in conjunction
with 10 mM KCl to promote depolarization.
4.2.2 Plasmids and Cell Lines.
The plasmids pEFP-RasGrf1 and pEFP-RasGrf2 (Anborgh et al., 1999), pCMX-rat TrkB
(wild-type and kinase-dead) have been described previously (Meakin and MacDonald,
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1998). HEK 293T cells (Graham et al., 1977) were cultured under standard conditions in
Dulbecco’s modified Eagle media (DMEM) with 5% supplemented calf serum (SCS) and
5% fetal bovine serum (FBS)(Hyclone) with 50 µg/ml gentamycin sulfate (Sigma). PC12
rat adrenal pheochromocytoma cells were maintained in DMEM with 5% SCS and 5%
horse serum (Hyclone). TrkB-B5 [nnR5 cells stably overexpressing HA-tagged TrkB
receptors (pCMX-HATrkB)] have been described previously (Meakin and MacDonald,
1998; Meakin, 2000). These cells were cultured in 5% SCS and 5% horse serum in the
presence of 100 µg/ml G418 and 50 µg/ml gentamycin sulfate.
4.2.3 Transfections, Immunoprecipitations, Western Blots.
Transfections were performed following standard calcium phosphate (HEK 293T) or
lipofectamine 2000 (PC12 cells, Invitrogen) transfection approaches (Jordan et al., 1996).
Lipofectamine transfection was performed according to manufacturer’s protocol with a
ratio of DNA to lipofectamine of 1:2. Basically, 1.5 x 106 cells (100 mm dish) were cotransfected with 0.5-5 µg of each indicated plasmid. Following 48 hrs expression, lysates
were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM Tris (pH
8.0), 0.5 mM EDTA) containing 1 mM PMSF, 1 mM sodium orthovanadate (NaVO4), 10
µg/ml aprotinin and 10 µg/ml leupeptin and assayed by immunoprecipitation. Lysates
containing 0.5 to 3.5 mg of protein (concentrations determined using the DC Protein
Assay Kit from Bio-Rad) were immunoprecipitated with 0.5 µg anti-Trk1478, 1 µg
Trk1494 (BioVision) or 1 µg anti-RasGrf1 as indicated, in addition to 5 µl of washed
Pansorbin (Calbiochem) or 2 µl γ-bind sepharose (Amersham Pharmacia Biotech) at 4 ºC
overnight. After washing three times with NP-40 lysis buffer, bound proteins were resuspended in 25 µl Laemmli sample buffer and heated at 65 °C for 10 minutes. Samples
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were then resolved on 6-12% SDS-polyacrylamide gels and transferred (5 volts, 1-2
hours) to PVDF membranes (Pall Life Sciences). Blocking prior to primary antibody
incubation was performed for 1 h at room temperature in 10 ml 10% milk powder and
phosphate buffered saline with tween-20 (TBS-T) or 2% BSA (for phospho-antibodies).
Westerns were blotted in 10 ml 10% milk powder with primary antibody at 4 ºC for 16 h
followed by washing in TBS-T for 30 minutes. Westerns were then incubated in 10 ml
10% milk powder and secondary antibody for 1 h at room temperature. Blots were
washed for 30 minutes in TBS-T and exposed to enhanced chemiluminescence reagents
(BioRad) and developed.
Primary antibody dilutions for western blotting are as follows: anti-RasGrf1 and
anti-RasGrf2 (Santa Cruz) 1:10,000; anti-RasGrf2 (Transduction Labs) (1:5000), antiTrk(1478) (1:20,000), anti-TrkB 1494 (1:5000), anti-TrkB monoclonal antibody
(Transduction Labs) (1:2000), anti-NR2B (1:2000), anti-NR2A (1:2000), anti-PSD95
(1:2000), anti-ShcC (1:2000) and anti-pTyr-100 (1:10,000). anti-phospho-p38 MAP
Kinase (1:2000), anti-p38 MAP Kinase (1:2000), anti-phospho-Erk p44/42 MAP Kinase
(1:5000) and anti-Erk p44/42 MAP Kinase (1:5000). HRP coupled goat anti-mouse and
goat anti-rabbit secondary antibodies were used at 1:10,000 dilution while HRP-coupled
rabbit anti-goat was used at 1:5000 dilution.
4.2.4 Neural Slice Analysis.
Post-natal day 30-35 male CD1 mice were killed with O2/CO2 and their cortices dissected
into the ice-cold-fresh- 95%O2/5%CO2 saturated Kreb’s Ringer Solution (11.1 mM
glucose, 1.1 mM MgCl2, 1 mM Na2HPO4, 1.3 mM CaCl2, 25 mM NaHCO3, 120 mM
NaCl, 4.7 mM KCl). Cortices were then embedded in 2% agarose and 300 µm coronal
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slices were cut with a vibrotome (frequency 8 Hz, speed 4 Hz). Four slices of cortex (10
slices of hippocampus) were placed into each well of a 6 well plate and incubated in 2 ml
Kreb’s Ringer Solution for 1 h at 37° C with 95% O2/5%CO2. Slices were then
stimulated for 15 minutes at 37 °C with 100 ng/ml BDNF, 100 µM NMDA with 10 mM
KCl. Slices were removed from Kreb’s Ringer and immediately lysed in lysis buffer A
(10 mM Tris-HCl pH7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM
PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 1 mM NaVO3). Samples were briefly
homogenized with a Polytron (2 × 30 second) followed by centrifugation at 1400 rpm for
10 minutes at 4° C. The supernatant was removed, transferred to microfuge tubes and
centrifuged again for 20 minutes at 4° C, 14,000 rpm (eppendorf Centrifuge 5417R,
Hamburg, Germany). A protein assay was performed on each sample using a Bio-Rad Kit
to determine the protein concentrations in each lysate. For co-immunoprecipitation in
neural slices, prepared lysates (750 µg to 1.5 mg) were pre-cleared with γ-bind sepharose
and normal mouse, goat or rabbit IgG (depending on specificity of the primary antibody
to be used) for one hour. Following centrifugation at 4 °C, 14,000 rpm, supernatants were
immunoprecipitated with anti- NR2B (1 µg), anti-TrkB (2 µg), anti-NR2A (1 µg) or IgG
(1 µg) (as a negative control) in LysisA buffer with 2 µl γ- bind sepharose for 16 h at 4
°C. Immunoprecipitations were washed twice in lysis buffer A, re-suspended in Laemmli
sample buffer with 100 mM dithiotreitol (DTT) and incubated at 70 °C for 10 minutes.
Samples were separated by 6% SDS-PAGE and western blotted with indicated
antibodies. For analysis of phosphorylation of Erk and p38 MAP kinase, Laemmli sample
buffer with 100 mM DTT was added to whole cell lysates from treated P16 or P30 slices
and samples incubated at 70 °C for 10 minutes. Samples were separated by 12% SDS-
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PAGE and western blotted as mentioned above. The band intensity was quantified using
a BioRad imaging system (ChemiDocTM). Relative densities were evaluated compared to
levels to that in the control lane as indicated in each figure. The means of three separate
slice preparation were evaluated. Relative densities were then statistically analysed by
paired student t-test for significant differences between two different stimulation
conditions.
4.3 Results
A coordination of TrkB and NMDA receptors through the downstream signaling
molecule, RasGrf1, was investigated in this study using post-natal day 30 (P30) acute
cortical slices after stimulation with either BDNF and/or NMDA. Since several studies
have suggested that RasGrf1 expression is regulated developmentally in the mouse brain
(Ferrari et al., 1994; Zippel et al., 1997) with a maximum level being expressed in adult
mouse cortex (2 months) (Li et al., 2006; Robinson, 2008), this study was performed of
an age that was optimal for RasGrf1 expression.
4.3.1 BDNF stimulation disrupts the interaction between NR2B and RasGrf1 in
neural slices.
As mentioned earlier, phosphorylation of Tyr1472 on the NR2B subunit of the
NMDA receptor is necessary to retain the receptors on the cell surface (Nakazawa et al.,
2001; Prybylowski et al., 2005; Wu et al., 2007). Moreover, a direct interaction between
the NR2B subunit of the NMDA receptor and RasGrf1 has been observed in primary cell
culture (Krapivinsky et al., 2003). Thus, the phosphorylation status of NR2B and changes
in RasGrf1 binding to NR2B were determined in adult mouse brain slices after
stimulation with either BDNF and/or NMDA. As shown in Figure 4.1A, while there is a
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basal level of Tyr1472 phosphorylation of NR2B under basal conditions (Figure 4.1A, left
panel, lane 1), this level of phosphorylation is increased more than 2-fold after BDNF
stimulation (lane 2). In comparison, co-stimulation with NMDA does not stimulate
Tyr1472 phosphorylation (Figure 4.1A, lane 3) and, in fact, decreases or prevents the
levels stimulated by BDNF (Figure 4.1A, left panel, lane 4). The expression level of
NR2B was verified by blotting with the anti-NR2B antibody (Figure 4.1A, lower panel).
Quantification of the levels of Tyr1472 phosphorylation is shown in the right panel (Figure
4.1A).
In addition, a small basal level of interaction between NR2B and RasGrf1 was
detected in the absence of BDNF/NMDA stimulation (Figure 4.1B, left, lane 1) relative
to negative control levels obtained with IgG (Figure 4.1B, lane 5), and this interaction
was significantly increased almost 2-fold in the presence of NMDA (Figure 4.1B, left, lane
3). However, an interaction between RasGrf1 and NR2B was not observed following
BDNF stimulation (Figure 4.1B, Lane 2) and the NMDA-induced increase in interaction
was lost in the presence of BDNF (Figure 4.1B, left, lane 4). This result suggests that
BDNF-mediated TrkB activation may regulate NMDA receptor signaling by stimulating
RasGrf1 dissociation from the NR2B subunit. The expression level of NR2B was verified
using the anti-NR2B antibody (Figure 4.1B, lower panel), and a quantification of the
levels of NR2B-RasGrf1 interaction, normalized to the level of NR2B, is shown in the
right panel (Figure 4.1B, right).
Since NR2A subunit of the NMDA receptor interacts with RasGrf2 (Li et al.,
2006), and the PH domain of RasGrf1 which mediates binding to Trk (Robinson et al.,
2005; Graham et al., 1977) is highly similar to the PH domain of RasGrf2; thus, BDNF-
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dependent changes in the interaction between NR2A and RasGrf2 was also tested. As
shown in Figure 4.1C, NR2A was co-immunoprecipitated with RasGrf2 in response to
NMDA (lane 5) stimulation relative to the negative control of IgG alone (Figure 4.1C,
lanes 1 and 2). However, no loss of NMDA-induced interaction was observed in the
presence of BDNF (Figure 4.1C, lane 6), which is in contrast to what was observed with
NR2B and RasGrf1. These data suggest that BDNF stimulation does not change the
interaction between NR2A and RasGrf2, and that BDNF-TrkB modulation of the NMDA
receptor is specific to RasGrf1 and NR2B.
4.3.2 BDNF stimulation increases the association of RasGrf1 towards TrkB.
A previous study indicated a direct interaction between Trk and RasGrf1 in
transfected HEK293 cells and consequently, the binding sites on both TrkB and RasGrf1
have been mapped (Robinson et al., 2005). Thus, the interaction between Trk and
RasGrf1 was also assessed by co-immunoprecipitation of lysates of P30 cortical slices to
determine the association of RasGrf1 to TrkB after BDNF stimulation.
As shown in Figure 4.2A, while there is a basal interaction between RasGrf1 and
TrkB before stimulation (Figure 4.2A, left, lane 3), relative to negative control of IgG
(Figure 4.2A, left, lane 7 and 8), this interaction was significantly increased almost 2.5fold upon BDNF stimulation (Figure 4.2A, left, lane 4) compared to unstimulated

condition, indicating that BDNF stimulation increases RasGrf1 association with TrkB. To
further verify the interaction between TrkB and RasGrf1, an immunoprecipitated sample
of HEK293 cells, transfected with TrkB and RasGrf1, and stimulated with BDNF was
also added to this study (Figure 4.2A, left, lane 1 and 2). The level of TrkB expression
was verified using an antibody against TrkB (Figure 4.2A, left lower panel), and a
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quantification of the level of interaction is presented in the right panel. Collectively, this
data as well as the results from the RasGrf1/NR2B dissociation studies suggest that
BDNF stimulation uncouples RasGrf1 from the NMDA receptor toward the TrkB
receptor.
The levels of TrkB and RasGrf1 tyrosine phosphorylation were then analyzed in
the P30 mouse cortical slices. As shown in Figure 4.2B (left panel), tyrosine
phosphorylation of TrkB was increased significantly after BDNF stimulation alone (lane
2), and the site of phosphorylation appeared to be Tyr516 on TrkB (Figure 4.2B, middle
panel), but not Tyr817 (Figure 4.2B, middle panel). The immunoprecipitation of TrkB was
verified in all treatment using an anti-TrkB antibody to detect TrkB expression (Figure
4.2B, lower panels). While TrkB was tyrosine phosphorylated in response to BDNF in
cortical slices, weak but insignificant levels of RasGrf1 tyrosine phosphorylation were
detected in both the presence of BDNF alone or in the presence of BDNF and NMDA
(Figure 4.2C).
4.3.3 BDNF stimulation modifies the ShcC adapter downstream of TrkB and PSD95 downstream of NR2B receptors.
In addition to a direct interaction between TrkB and RasGrf1 in response to
BDNF, Shc has also been shown to be tyrosine phosphorylated (Figure 4.3A), and
interact with Trk (Figure 4.3B), in the presence of BDNF alone and upon stimulation by
both BDNF and NMDA in P30 cortical slices (Figure 4.3B, lanes 2 and 4), but not in the
presence of NMDA alone (lane 3) (Robinson, 2008). Furthermore, since RasGrf1 is
highly expressed at post-synaptic densities (Zippel et al., 1997) and the post-synaptic
density protein 95 (PSD-95) is a major regulator of NMDA receptor signalling, that
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facilitates the phosphorylation of NR2B by Src family kinases (van Zundert et al., 2004).
Thus, it is likely that NMDA would facilitate an interaction between NR2B and PSD-95.
As shown in Figure 4.3C (Robinson, 2008), a basal level of interaction was observed
between NR2B and PSD-95 in absence of any treatment (lane 1), but this interaction was
remarkably increased in treatment by NMDA alone (lane 3) similar to what observed
between RasGrf1 and NR2B (Figure 4.1B, lane 3).
Since we found that the site of BDNF-induced tyrosine phosphorylation on TrkB
was tyrosine516 (Figure 4.2B), the docking site for ShcC (Minichiello, 2009), I addressed
whether ShcC might also form a complex with RasGrf1 which binds the adjacent HIKE
domain (His531 to Glu542) on TrkB and whether RasGrf1 might form part of a signalling
complex downstream of the NMDA receptors. Thus, I tested for direct interactions
between RasGrf1 and both PSD-95 and ShcC under basal or stimulated conditions.
However, no interaction was observed between RasGrf1 and either ShcC or PSD-95 in
response to either BDNF or NMDA stimulation in this study (Figures 4.3D and 4.3E).
4.3.4 BDNF stimulation alters NMDA-mediated Erk and p38-Map Kinase
phosphorylation in an age specific manner.
A study by Li et al (2006) suggests that NR2B/RasGrf1 interaction increases the
activation of p38, while NR2A/RasGrf2 interaction enhances the activation of Erk 1 and
2 (Li et al., 2006). Thus, the phosphorylation levels of the p38 and Erk MAP-kinases
were evaluated in this study, in response to BDNF and/or NMDA.
As shown in Figure 4.4A, a basal level of Erk1/2 was observed under basal
conditions (Figure 4.4A, lane 1). Subsequently, a small but significantly higher level of
Erk phosphorylation was observed in response to 15 minutes of BDNF stimulation
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relative to the unstimulated condition (lane 2). While NMDA treatment did not stimulate
a change in levels of Erk phosphorylation relative to controls, a significant decrease in
Erk1/2 phosphorylation was observed after treatment with both BDNF/NMDA (Figure
4.4A, lane 4) relative to that observed with BDNF treatment alone. The levels of Erk
expression are shown in the lower panel of Figure 4.4A and a quantification of the levels
of Erk phosphorylation is shown in the right panel.
With respect to p38, I found basal levels of p38-MAP kinase phosphorylation
under both basal conditions and following BDNF stimulation (Figure 4.4B, lane 2). In
contrast, I observed a substantial increase (almost 2-fold) in the levels of p38
phosphorylation upon NMDA treatment (lane 3). When slices were co-stimulated with
both BDNF/NMDA, there was a slight decrease, that was not statistically significant, in
the level of p38-MAP kinase phosphorylation and the levels of phosphorylation were still
significantly higher than unstimulated controls (lane 4). Quantification of the levels of
p38 phosphorylation, are shown in the right panel. Collectively, these observations
suggest that BDNF stimulation modulates the activity of Erk and p38-MAP kinase
downstream of NMDA receptor.
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Figure 4.1. The phosphorylation of NR2B and its interaction with RasGrf1 in P30
brain slices. Cortical slices were lysed after BDNF and/or NMDA stimulation, and 3 mg
lysates were immunoprecipitated (IP) with the NR2B or NR2A antibodies. Ips or a whole
cell lysate (WCL; 100 µg) were analyzed by SDS-PAGE, and blotted (IB) with the
indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of indicated
condition relative to unstimulated condition. A) Tyrosine1472 phosphorylation assessment
of NR2B subunit in WCL in response to BDNF and/or NMDA (n=3). The level of
Tyr1472 phosphorylation was increased more than 2-fold in the presence of BDNF relative
to the unstimulated lane. Relative density of this phosphorylation levels are shown in the
right panel. The blots were normalized to the level of NR2B expression. B) Interaction
between NR2B and RasGrf1 upon BDNF and/or NMDA stimulation in P30 slices. NR2B
interaction with Ras-Grf1 was increased almost 2-fold in response to NMDA relative to
the unstimulated lane, and BDNF prevents this interaction. Goat immunoglobulin (IgG)
was used as a negative control. A quantification of the interaction levels are shown in the
right panel. Blots were normalized to the levels of NR2B expression. C) The interaction
between NR2A and RasGrf2. BDNF stimulation does not change the interaction between
RasGrf2 and NR2A (Robinson, 2008).
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Figure 4.2. The interaction between Trk and RasGrf1 and the level of Trk/RasGrf1
phosphorylation in P30 brain slices. Cortical slices were lysed after BDNF and/or
NMDA stimulation, and 2 mg of lysates immunoprecipitated (IP) with Trk (C-14) or
RasGrf1 (C-20) antibodies. Ips or a whole cell lysates (WCL; 100 µg) were analyzed by
SDS-PAGE, and blotted (IB) with the indicated antibodies (n=3). * indicates statistical
significance (P-value<0.05) of indicated condition relative to unstimulated condition. A)
Interaction between Trk and RasGrf1 (n=3). An enhanced interaction (almost 3-fold)
between TrkB and Ras-Grf1 is evident in response to BDNF relative to the unstimulated
lane,.Co-stimulation with NMDA decreases this interaction. Rabbit immunoglobulin
(IgG) was used as a negative control for immunoprecipitation. A quantification diagram
of the interaction between Trk and RasGrf1, normalized to the level of Trk in each lane,
is shown in the right panel. B) Tyrosine phosphorylation of TrkB. BDNF stimulation
increases the tyrosine phosphorylation of tyrosine516, not tyrosine817, on TrkB. C)
Tyrosine phosphorylation of RasGrf1. A weak-insignificant level of tyrosine
phosphorylation is detectable in the presence of BDNF and both BDNF/NMDA
treatment.
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Figure 4.3. Western blot analysis of complex signaling molecules downstream of
TrkB and NR2B in P30 mouse brain slices. Cortical slices were lysed after BDNF
and/or NMDA stimulation, and immunoprecipitated (IP) with the indicated antibodies.
Ips or whole cell lysates (WCL) were analyzed by SDS-PAGE and blotted (IB) with the
indicated antibodies (n=3). A) The level of ShcC phosphorylation upon BDNF
stimulation. ShcC tyrosine phosphorylation is increased in the presence of BDNF
(Robinson, 2008). B) The interaction between ShcC and TrkB after BDNF and/or NMDA
stimulation. BDNF stimulation increases Trk-ShcC interaction (Robinson, 2008). C) The
interaction between PSD-95 and NR2B after BDNF and/or NMDA stimulation. NMDA
stimulation increases the NR2B-PSD-95 association (Robinson, 2008). D) The
interaction between ShcC and RasGrf1, as being part of a complex, after BDNF and/or
NMDA stimulation. No interaction was observed between RasGrf1 and ShcC in any
condition. E) The interaction between PSD-95 and RasGrf1, as being part of a complex,
after BDNF and/or NMDA stimulation. No interaction was observed between RasGrf1
and PSD-95 in any condition.
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Figure 4.4. The activation of Erk/p38 MAP-kinase activation upon BDNF and/or
NMDA stimulation. Cortical slices were lysed after BDNF and/or NMDA stimulation,
and a whole cell lysates (WCL; 100 µg) were analyzed by SDS-PAGE, and blotted (IB)
with indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of
indicated condition relative to unstimulated. A) The phosphorylation of Erk in P30 slices
after BDNF and/or NMDA stimulation. The level of Erk phosphorylation is increased
significantly after BDNF stimulation alone relative to the unstimulated lane, and was
decreased in combination treatment relative to BDNF alone. Quantification of Erk
phosphorylation, normalized to levels of Erk expression, is shown in the right panel. **
indicates significant decrease of combination treatment relative to BDNF alone. B) The
phosphorylation of p38 in P30 slices after BDNF and/or NMDA stimulation. NMDA
stimulation alone increased significantly (almost 2-fold) the level of p38 phosphorylation,
relative to unstimulated cells, and the level of phosphorylation was decreased in
combination treatment. Quantification of p38 phosphorylation, relative to levels of p38
expression, is shown in the right panel.
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Figure 4.5. A schematic diagram depicting the proposed model of RasGrf1-mediated
cross-talk between TrkB and NMDA receptors. Note that intracellular Ca2+ is a key
determinant in generating LTD or LTP. In the absence of BDNF (A), RasGrf1 binds to
the NR2B subunit of the NMDA receptor. Subsequently, p38-MAP kinase is activated
predominantly through Rac-GTPases. This activation leads to NMDA receptor
internalization, low Ca2+ influx and LTD. In the presence of BDNF (B), TrkB is
activated, leading to Src-mediated phosphorylation of NMDA receptor on Tyr1472. NR2B
is stabilized on cell surface which blocks LTD, consequently intracellular Ca2+ levels are
increased, result in activation of PKA, and phosphorylation of RasGrf1 at Ser916 with
the resultant dissociation of RasGrf1 from the NR2B. This dissociation allows for the
RasGrf1 to directly interact with TrkB and mediate the activation of signaling pathways
leading to neuritogenesis. Increase in the level of intracellular Ca2+ also associate NMDA
receptor to LTP on receptor level.
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4.4 Discussion
LTP and LTD, two molecular processes contributing in learning and memory
formation, are regulated in part by the NMDA receptor in the hippocampus area of the
brain, and it has been suggested that BDNF increases both hippocampal presynaptic and
postsynaptic transmission by regulating the activity of the NMDA-NR2B receptor
(Levine and Kolb, 2000). Through postsynaptic TrkB receptor activation, BDNF
increases the NMDAR single-channel-open probability associated with both LTP and/or
LTD. In fact, it has been shown that blocking the NR2B subunit of the NMDAR inhibits
LTD with no effect on LTP, while NR2A inhibition prevent LTP induction but not LTD
(Lu et al., 2008; Liu et al., 2004). In this regard, synaptic plasticity is associated with an
increase in MAP kinase family members activated downstream of both NMDA receptors
(Levine and Kolb, 2000), and BDNF-mediated TrkB receptors. While several documents
have addressed the nature of the cross talk between NMDAR and TrkB, the signalling
pathways downstream of these receptors are not fully understood.
Previous results from the Meakin Lab (Robinson, 2008) indicate that RasGrf1 is
expressed at very low levels in the neonate, and levels rise developmentally with the
maximum expression predominantly in the mature brain (>P30) which was consistent
with a previous study (Zippel et al., 1997). Thus, all analyses in this study have been
addressed in P30 CD1 mice. Moreover, acute cortical slices including cortex and
hippocampus were used in this study as these areas have been suggested to express
BDNF and TrkB associated with plasticity, LTP and LTD (Li et al., 2006). Consequently,
BDNF stimulation appeared to sustain Tyr1472 phosphorylation of the NR2B subunit of
the NMDA receptor similar to what has been observed in other studies (Lin et al., 1998;
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Levine et al., 1998; Levine and Kolb 2000). As mentioned earlier, the phosphorylation of
NR2B-Tyr1472 is crucial to retain NMDA receptor on cell membrane (Nakazawa et al.,
2001; Prybylowski et al., 2005).
Moreover, there was a direct interaction between the NR2B subunit of the NMDA
receptor and RasGrf1 in the presence of NMDA in P30 cortical slices which is in
agreement with previous studies (Kraivinsky et al., 2003; Li et al., 2006), and the level of
interaction was reduced remarkably by the addition of BDNF. In vitro studies in TrkB-B5
cells further verified that NMDA treatment increases the association of NR2B with
RasGrf1 similar to that observed using brain slices (Robinson, 2008).
A relevant interaction was also observed between TrkB and RasGrf1 in P30
cortical slices in response to BDNF stimulation, which is consistent with previous
observations in HEK293 cells (Robinson et al., 2005). BDNF stimulation increased
tyrosine phosphorylation of the TrkB receptor at Tyr516, equivalent to Tyr499 on TrkA,
which is the docking site for the ShcC adaptor protein (Minichiello, 2009). Since this site
is close to the HIKE domain (His507-Glu518) on TrkA, the binding site of RasGrf1, the
question arose as to whether ShcC might be interacting with RasGrf1. While a direct
interaction between TrkB and ShcC was observed after BDNF stimulation, no direct
interaction between ShcC and RasGrf1 was observed.
Furthermore, an increase in interaction between NR2B and PSD-95 was also
observed upon NMDA treatment (Robinson, 2008), and a loss of this interaction occurred
following the addition of BDNF similar to what was observed between NR2B and
RasGrf1, suggesting that RasGrf1 might be part of a complex with the PSD-95
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intermediate signalling molecule. However, when interactions between PSD-95 with
RasGrf1 were examined, no interactions were observed.
While both NGF and BDNF have been shown to stimulate tyrosine
phosphorylation of RasGrf1 in transfected cells in culture (Robinson et al., 2005; Chapter
2), I was unable to detect sufficient levels of RasGrf1 tyrosine phosphorylation in this
study, even by using 20 mg of lysates (data not shown). This data suggests that RasGrf1
either is not phosphorylated in vivo, opposite to what we have observed in vitro, or that
the levels of phosphorylation are stoichiometrically low and can only be detected in other
conditions such as using higher levels of lysate, specifically examining post synaptic
density fractions or using a more specific antibody in future studies.
In this study, the phosphorylation of the Erk/MAP kinase after BDNF treatment
alone was increased significantly compared to that observed in untreated conditions while
the level of p38 phosphorylation was increased significantly after NMDA stimulation . In
fact, this data suggests that interaction between RasGrf1 and TrkB has been associated
with an increase in Erk-MAP kinase phosphorylation while interaction between RasGrf1
and NR2B has been associated with an increase in p38-MAP kinase phosphorylation.
This data is not in agreement to what observed in the study by Krapivinsky et al., (2003)
in which an interaction between RasGrf1 and NR2B has been associated with increased
in Erk phosphoryation. In contrast, the results presented here agree with the study by Li
et al (2006) in which the interaction between RasGrf1 and NR2B specifically activated
p38 MAP Kinase but not Erk associated with increases in long-term depression, while the
association of RasGrf2 with NR2A facilitates Erk activation with the result of promoting
LTP (Li et al., 2006).

138
Furthermore, in terms of regulating the balance between Erk and p38-MAP kinase
phosphorylation by either BDNF or NMDA, it appears that the NMDA- mediated NR2B
activation shows a stronger influence than the BDNF-mediated TrkB activation as the
combination treatments in Erk-MAP kinase phosphorylation, adding NMDA to BDNF
significantly blocked Erk phosphorylation while in p38-MAP kinase phosphorylation
assessment, adding BDNF to NMDA only slightly decreased p38 phosphorylation. These
observations suggest that RasGrf1 might initiate part of a signalling pathway upstream of
Erk and that some other signalling molecules with distinct consequences rather than
RasGrf1-mediated neuronal growth might be also involved in Erk phosphorylation. Since
RasGrf2 associates with NR2A to facilitate the activation of Erk (Li et al., 2006) and
since the interaction between NR2A and RasGrf2 was unaffected by BDNF, I expected to
observe a slight increase in the level of Erk activation. While this additive effect was not
observed under the conditions used, it is possible that it is transitory or may be revealed
in another time point or by performing more careful analyses of the kinetics of Erk
activation in slice cultures. Moreover, the distinct role(s) of RasGrf1 and RasGrf2 in
mediating Erk activation need to be further investigated, and future studies using slices
from RasGrf1 and RasGrf2 knockout mice could verify distinct roles of each in
regulating in Erk activation.
This study presents important data demonstrating that signalling cross-talk occurs
in response to BDNF and NMDA stimulation within cortical and hippocampal slices of
the brain (see proposed model in Figure 4.5). While BDNF recruits and couples both
ShcC and RasGrf1 to the TrkB receptor, the later of which is uncoupled from the NR2B
subunit of the NMDA receptor, co-stimulation with NMDA uncouples RasGrf1 from
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TrkB but does not affect TrkB binding to ShcC. Conversely, while NMDA stimulates
NR2B binding to PSD-95, co-stimulation with BDNF uncouples this interaction. The
evaluation of co-ordination between TrkB, NR2B and RasGrf1 in specific regions, such
as postsynaptic density, may further clarify the nature of this signalling pattern.
Since RasGrf1 increases neurite outgrowth in PC12 cells upon NGF and BDNF
stimulation, and given the fact that TrkB regulates dendritic spine density and synapse
formation, the evaluation of hippocampal neurons from RasGrf1 knockout mice in the
presence of BDNF may identify a potential role of RasGrf1 and TrkB in neurons to
modulate potential synaptic morphology. It would be interesting to investigate if BDNF
and/or NMDA stimulation affects dendritic spine density in wild-type versus RasGrf1
knockout hippocampal cultures to address whether NR2B activation of p38-MAP kinase
and LTD are associated with a loss of dendritic spines. Furthermore, RasGrf1-siRNA
could be used to knock down RasGrf1 expression in hippocampal cell cultures in the
absence and presence of BDNF and evaluate dendritic spine density.
Collectively, a novel signalling pathway was identified in this study within the
mature brain where BDNF-mediated TrkB activation modifies NMDA receptor
signalling pathway through RasGrf1 to link synaptic plasticity to neuronal differentiation.
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Chapter 5
General Discussion and Conclusions
The mechanism of coordination between TrkB and NMDA receptor through RasGrf1
has been addressed in this study and the possible signaling molecules downstream of
RasGrf1 were investigated.
Initially to understand a role for RasGrf1 in cell differentiation, RasGrf1-mediated
neurite outgrowth was determined in an in vitro neuronal-like model, PC12 cells and
TrkB receptor over-expressing cells. It appeared that RasGrf1 activates both Ras and Rac
during neurotrophin-mediated neurite outgrowth (Chapter 2). By using several
domain/site- directed mutants of RasGrf1 in a comparison study including NGF-mediated
neurite outgrowth in PC12 cells versus BDNF-mediated in TrkB-B5 cells, it has been
revealed that both Ras and Rac-GTPases are essential in neurotrophin-mediated
enhancement of neurite outgrowth through RasGrf1. This notion is consistent with other
studies in which RasGrf1 activates Ras in HEK cells downstream of the non-receptor
tyrosine kinase ACK1, cAMP-activated PKA, calcium and GPCR activity (Mattingly,
1999; Kiyono et al., 2000b; Yang et al., 2003). Conversely, RasGrf1 activates Rac
downstream of the non-receptor tyrosine kinase Src (Kiyono et al., 2000a). Furthermore,
Baldassa et al., (2007) have shown that RasGrf1 interacts with a microtubuledestabilizing factor SCLIP (SCG10-like protein) which inhibits its ability to promote Rac
activation and neurite outgrowth (Baldassa et al., 2007).
It has been denoted in this study to take extreme precaution regarding the expression
of endogenous H-Ras while using the PC12 cell line, as the level of endogenous H-Ras
could explain some differences in the results of various studies performed in PC12 cells.
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For instance, Yang and Mattingly (2006) reported no detectable levels of endogenous HRas expression in their PC12 cell line and they found a requirement for H-Ras coexpression in order to stimulate neurite extension. Moreover, they reported no role for
Rac in this process; rather, they have suggested that the expansion in soma size in cotransfected cells was dependent on Rac activity (Yang and Mattingly, 2006). In contrast,
in this study and others (Baldassa et al., 2007), the level of endogenous H-Ras was
detectable and it was sufficient to induce neurite outgrowth in presence of RasGrf1
expression. Consistently, Baldassa et al., (2007) observed a specific requirement for Rac
activation by RasGrf1 in mediating constitutive neurite extension in PC12 cells. In
addition, in this study, I found that the co-expression of H-Ras with RasGrf1 in PC12
cells highly induced neurite outgrowth, and could completely eliminate the ability to
detect Rac activity in neurotrophin-induced neurite outgrowth. In fact, some researchers
have also reported that Ras is able to bind and activate b-Raf and small G proteins
associated with differentiation under conditions of high levels of Ras expression (Kao et
al., 2001).
In addition to the evidence provided here to indicate RasGrf1 regulation of Ras
family GTPase activation, some essential sites of RasGrf1 tyrosine phosphorylation for
neurite outgrowth were also evaluated (Chapter 3). Using site directed mutagenesis
targeting of several domains/sites of RasGrf1, a novel site of tyrosine phosphorylation
was identified in the CDC25 domain. While 2 sites of Trk-induced tyrosine
phosphorylation were identified in the PH1 and IQ domains of RasGrf1 (Tyr95 and
Tyr233), these were not essential to support NGF-induced neurite outgrowth in PC12 cells.
In instead, Tyrosine 1048 and/or tyrosine 1062 in the CDC25 domain appeared to be
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crucial for RasGrf1 phosphorylation and to support neurotrophin-mediated neurite
outgrowth. Further studies are required to understand whether one or both tyrosine sites
are necessary for RasGrf1 tyrosine phosphorylation. Further study is also required to test
other tyrosine sites within CDC25 domain and the Rac activation domain (DH domain)
which might be involved in RasGrf1 tyrosine phosphorylation for neurotrophin-mediated
neurite outgrowth.
Collectively, our study focused on both NGF and BDNF-dependent RasGrf1
enhancement of neurite outgrowth through specific Ras family GTPases to advance our
understanding about a potential role for RasGrf1 in mediating Trk-dependent synaptic
plasticity. Synaptic plasticity is regulated in part by NMDA receptors in the hippocampal
area of brain, where BDNF-mediated TrkB receptor activation increases both presynaptic
and postsynaptic transmission and regulates the activity of the NMDA-NR2B receptor
(Levine and Kolb, 2000) although the mechanism of the coordination between two
receptors and the downstream signalling pathways have not been fully understood.
Consistent with the studies suggesting that BDNF increases phosphorylation of
the NMDA receptor (Lin et al., 1998; Levine et al., 1998; Levine and Kolb, 2000), we
have provided evidence showing that in cortical slices (Chapter 4), BDNF stimulation
increases tyrosine1472 phosphorylation of the NR2B subunit of NMDA receptor, the site
of which is crucial to retain NMDA receptors at the cell membrane (Nakazawa et al.,
2001; Prybylowski et al., 2005).
On one hand, a direct interaction between the NR2B subunit and RasGrf1 has
been observed in the presence of NMDA in both P30 cortical slices and TrkB-B5 cells
(Robinson, 2008) which is in agreement with previous studies (Li et al., 2006; Kraivinsky
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et al., 2003), and the level of interaction was reduced remarkably by addition of BDNF,
suggesting that NMDA stimulation couples RasGrf1 to the NR2B subunit of the NMDA
receptor while BDNF stimulation uncouples RasGrf1 from the NR2B subunit. On the
other hand, a novel interaction was also observed between TrkB and RasGrf1 upon
BDNF treatment in P30 cortical slices, which is consistent with similar observation in
HEK293 cells (Robinson et al., 2005). Yet, no discernible detectable level of RasGrf1
phosphorylation was observed in this interaction, suggesting that RasGrf1 either is not
phosphorylated in vivo at all, opposite to what we have observed in vitro, or that the level
of phosphorylation, or its relative stoichiometry, is lower than what we can detect with
the currently available antibodies. Thus, to provide a more enriched lysate for the
detection of RasGrf1 tyrosine-phosphorylation, a post synaptic density preparation is
recommended for future studies. Altogether, these observations suggest that BDNF
stimulation associates RasGrf1 with the Trk receptor while dissociating it from the NR2B
subunit. BDNF stimulation increased tyrosine phosphorylation of the TrkB receptor on
Tyr516, the site which is equivalent to Tyr499 on TrkA and serves as a docking site for the
ShcC adaptor protein (Minichiello, 2009). This notion was further verified by a observing
a direct interaction between TrkB and ShcC after BDNF stimulation with a loss of this
interaction after NMDA stimulation (Robinson, 2008).
The interaction between NR2B subunit and PSD-95 was also increased upon
NMDA treatment (Robinson, 2008), and a loss of this interaction by the addition of
BDNF was observed, similar to what was observed between the NR2B and RasGrf1,
suggesting that RasGrf1 might be part of a complex with PSD95 intermediate signalling
molecule. However, when RasGrf1 co-interaction with PSD95 intermediate signalling
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proteins was tested, no interaction was detected between RasGrf1 and PSD95 under the
condition in our study. Although it cannot be ruled out that there might be an interaction
between RasGrf1 and PSD95 under other conditions such as in post-synaptic density
preparation, which needs to be further addressed in future studies.
To evaluate the activation of Erk/p38 MAP kinases downstream of RasGrf1, this
study revealed that the phosphorylation of Erk MAP kinase was increased after 15 min
BDNF treatment while NMDA treatment increased the phosphorylation of p38 MAP
kinase. Although this observation is not in agreement with what was observed in the
study by Krapivinsky et al., (2003), in which the interaction between RasGrf1-NR2B was
associated with preferentially increased levels of Erk phosphoryation (Krapivinsky et al.,
2003), this result did agree with the study by Li et al., (2006). They showed that the
interaction between RasGrf1 and the NR2B predominantely activated p38 MAP Kinase
resulting in increases in long-term depression while the association of RasGrf2 with
NR2A facilitates Erk activation with the result of promoting LTP ( Li et al., 2006).
However, RasGrf1 and RasGrf2 may activate Erk through distinct pathways which need
to be further investigated in future studies. Application of RasGrf1 and RasGrf2 knockout
mice for the purpose of slice preparation could verify distinct roles of both RasGrf1 and
RasGrf2 in the regulation of Erk activation in future studies.
The coupling of NMDA receptor to Erk in the study by Krapivinsky et al., (2003)
could be due to several reasons including whether the study had been performed in
cultures or slices, the age of the mouse, and the specific region of the brain studied, all of
which have been shown to affect the activation of signalling pathways downstream of the
NMDA receptor (Tovar and Westbrook, 1999). Collectively this data suggests that
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NMDA stimulation couples RasGrf1 to the NR2B subunit of the NMDA receptor to
activate p38 MAP kinases while BDNF stimulation couples RasGrf1 to TrkB to activate
Erk MAP kinases.
To further verify RasGrf1-mediated coordination of Trk and NMDA receptors, it
would be interesting to perform some inhibition experiments in future studies. For
instance, since elevation in intracellular calcium promotes RasGrf1 activation as an
intracellular calcium sensor, and it is involved in regulating the prolonged activation of
the NMDA receptor, brain slices could be treated with an intracellular calcium chelator,
BAPTA-AM, to determine if BDNF-induced RasGrf1 dissociation from the NR2B
subunit of the NMDA receptor is affected, as well as whether BDNF/NMDA induces
changes in Erk and/or p38 MAP kinase activation. Moreover, in this regard, the
application of the NR2B inhibitor (Ifenprodil), Erk inhibition (by MEK inhibitor; U0126)
or P38 inhibitor (SB230580) could also further clarify the changes in Erk or p38 MAP
kinase activation in the RasGrf1-mediated coordination of Trk and NMDA receptor.
To further address the role of RasGrf1 mediation of neurite outgrowth and neural
plasticity, one of the most important regulators of RasGrf1 to study is Cyclin-dependent
kinase 5, Cdk5. Cdk5 is a member of the cyclin-dependent kinase family. It is a prolinedirected serine/threonine kinase and crucial to the proper modulation of neurite formation
and structure, neurite outgrowth and neuronal migration during brain development as
well as learning and memory (Zhange et al., 2008). It has been shown that Cdk5 interacts
with Trk and NMDA receptors as well as with RasGrf1. In fact, Cdk5 has been shown to
phosphorylate RasGrf1 resulting in RasGrf1 degradation (Kesavapany et al., 2006). TrkB
also interacts with Cdk5 as a substrate through which BDNF stimulation enhances Cdk5
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activity resulting in dendritic growth (Cheung et al., 2007). In addition, Cdk5 regulates
the activity of the NMDA receptor by decreasing NR2B phosphorylation and increasing
receptor internalization (Zhange et al., 2008). How TrkB and NMDA receptors, as well
as RasGrf1, may regulate Cdk5 activity and function is another question to be
investigated in a future study. In this regard, brain slices can be treated with a Cdk5
inhibitor, Roscovitine, before stimulation with BDNF/NMDA and assay changes in the
level of RasGrf1 expression, its phosphorylation status, possible interaction with the
TrkB/NR2B as well as changes in Erk/p38 MAP activities under these conditions. In
addition, the localization study of RasGrf1 with either TrkB or the NR2B in specific
regions of brain, such as postsynaptic density, may further clarify the nature of the
signalling pattern down stream of both receptors.
Using RasGrf1 knockout mice would also extensively clarify the RasGrf1
modulation of TrkB-NR2B during neuronal growth and synaptic plasticity. RasGrf1
knockout (-/-) mice exibit a severe deficit in amygdala-dependent synaptic plasticity with
high synaptic activity in amygdala and hippocampal neurons (Brambilla et al., 1997), as
well as impaired hippocampal-dependent plasticity evidenced as failures in performing
hippocampal-dependent behavioral tests such as the Morris water maze, contextual
discrimination and social transmission of food preferences (Giese et al., 2001). Thus, it
would be interesting to perform hippocampal cell cultures from wild-type versus RasGrf1
knockout mice to clarify whether BDNF-mediated Trk activation affects dendritic spine
density, and whether NMDA-mediated NR2B activation are associated with a loss of
dendritic spines. The activation of Rac and/or Ras-GTPases, as well as p38 and/or ErkMAP kinases downstream of RasGrf1 can also be compared in both wild type and
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RasGrf1 knockout mice. This experiment can be examined either in intact cells or cells
transfected with RasGrf1 plasmids, including RasGrf1-wild type, RasGrf1-DH domain
mutant lacking binding site for Rac, and RasGrf1-CDC25 domain mutant lacking binding
site for Ras. In this regard, as Post-natal day 3-5 is the optimum age in which RasGrf1 is
expressed optimally, post-natal day 3-5 hippocampal cells from RasGrf1 knockout (-/-)
and wild type mice could be cultured in the presence and absence of BDNF/NMDA, and
dendrite spines assessed by immunohistochemically (IHC) using the dendritic spine
marker, microtubule associated protein-2 (MAP-2), tubulin (axon marker), or Drebrin- an
actin binding protein, and changes in cell morphology, including the length, count, size
and intensity of dendrites could be determined statistically.
Furthermore, a study by Li et al (2006) suggested that the interaction between
RasGrf1 and NR2B specifically activated p38 MAP Kinase, but not Erk with increases in
LTD while the association of RasGrf2 with NR2A facilitates Erk activation that results in
the promotion of LTP. However, RasGrf1 and RasGrf2 may activate Erk through distinct
pathways which need to be further investigated in a future study. In this respect, slice
preparations from RasGrf1 knockout mice could aid in verifying a distinct role for both
RasGrf1 and RasGrf2 in Erk activation.
Altogether, in this study two novel signalling pathways have been identified.
First, that RasGrf1 facilitates neurotrophin-dependent neurite outgrowth via both Ras and
Rac and that this requires tyrosine phosphorylation of RasGrf1 within the Cdc25 domain.
Secondly, I have identified a mechanism whereby BDNF-mediated activation of TrkB
may regulate the process of learning and memory. Specifically, within the mature brain I
demonstrate that BDNF-mediated TrkB activation can modify NMDA receptor signalling
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by specifically uncoupling RasGrf1 from NR2B while not affecting the association of
RasGrf2 with NR2A. Since RasGrf1 signaling via NR2B is associated with LTP, this
provides a potentially important mechanism by which TrkB may be facilitating the
process of learning and memory. In addition to decreasing the potential of NMDA
signaling to result in LTD, which may indirectly facilitate a potential increase in LTP, the
potential for RasGrf1 to facilitate TrkB-mediated dendritic growth and spine formation
may provide another means by which TrkB signaling may facilitate the process of
learning and memory (see the proposed model in Figure 4-5).
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